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 ABSTRACT 
 
This study was done to detect the drug-resistance organisms in 
Khartoum State. Samples were collected from Khartoum, Bahri, Haj Elsafi 
and Omdurman hospitals and Faculty of Veterinary Medicine Khartoum 
University.  
A total of one hundred and fifteen samples and swabs were collected 
from infected human wound, human abscesses, infected human ear, infected 
equine uterus, mastitic cows and goat’s milk and infected poultry tissues.  
The totals of one hundred and fifty three isolates were obtained and 
these isolates were belonging to Staphylococcus spp., Streptococcus spp., 
Corynebacterium spp., Bacillus spp., E.coli, Klebsiella spp and 
Pseudomonas spp.  
Staphylococcus species were isolated in this study include Staph. 
aureus, Staph. delphini, Staph. intermedius, Staph. caseolyticus, Staph. 
cohni, Staph. sciuri and Staph.epidermidis.   
In this study, the sensitivity of ninety-eight isolates to twenty-one 
antimicrobial drugs was examined. Very high resistance to antimicrobial 
agents was observed. Staphylococci spp. were highly resistance to 
ampicillin (92.9%) and Enterobacteriaceae (88.9%) to ampicillin. The 
Streptococcus spp. and Corynebacterium spp. were completely resistance to 
nalidixic acid and methicillin (100%). Enterobacteriaceae and Pseudomonas 
spp. were completely resistance to penicillin and vancomycin (100%). 
While Staphylococci spp. was highly resistance to penicillin (97.9%). 
 Streptococci spp. was highly resistance to penicillin (85.7%). Also 
Streptococci spp. were completely resistance to colistin sulphate, 
cotrimoxazole, methicillin and clindamycin (100%).   
Multi-drug resistance was shown by most of the bacteria strains 
isolated in this study. The multiple drug resistance observed varied from 
two drugs multiple resistances (ampicillin and penicillin) to eleven drug 
multiple resistances (ampicillin, streptomycin, cloxacillin, penicillin, 
vancomycin, rifampicin, erythromycin, methicillin, tetracycline, 
cephalothin and clindamycin).  
  ﻣﻠﺨﺺ اﻷﻃﺮوﺣﺔ
ﻭﻗﺪ ﰎﹼ ﲨﻊ ﺍﻟﻌﻴﻨﺎﺕ ﻣﻦ . ﲤﺖ ﻫﺬﻩ ﺍﻟﺪﺭﺍﺳﺔ ﻟﻜﺸﻒ ﺍﻟﺒﻜﺘﲑﻳﺎ ﺍﳌﻘﺎﻭﻣﺔ ﻟﻠﻤﻀﺎﺩﺍﺕ ﺍﳊﻴﻮﻳﺔ ﰲ ﻭﻻﻳﺔ ﺍﳋﺮﻃﻮﻡ 
-ﻦ ﻛﻠﻴﺔ ﺍﻟﻄﺐ ﺍﻟﺒﻴﻄﺮﻱﻣﺴﺘﺸﻔﻰ ﺍﳋﺮﻃﻮﻡ ﻭ ﻣﺴﺘﺸﻔﻰ ﲝﺮﻱ ﻭﻣﺴﺘﺸﻔﻰ ﺣﺎﺝ ﺍﻟﺼﺎﰲ ﻭﻣﺴﺘﺸﻔﻰ ﺃﻣﺪ ﺭﻣﺎﻥ ﻭﺃﻳﻀﺎﹰ ﻣ
  . ﺟﺎﻣﻌﺔ ﺍﳋﺮﻃﻮﻡ
أﻣﺎ . ﺗّﻢ ﺟﻤﻊ ﻣﺎﺋﺔ وﺧﻤﺴﺔ ﻋﺸﺮ ﻋﻴﻨﺔ ﻣﻦ اﻟﺠﺮوح و اﻟﺪﻣﺎﻣﻞ و اﻵذان اﻟﻤﺼﺎﺑﺔ ﻓﻲ اﻹﻧﺴﺎن 
ﻓﻲ اﻟﺤﻴﻮان ﻓﻘﺪ ﺗّﻢ ﺟﻤﻊ اﻟﻌﻴﻨﺎت ﻣﻦ أرﺣﺎم اﻷﻓﺮاس اﻟﻤﺼﺎﺑﺔ وﻣﻦ أﻟﺒﺎن اﻷﺑﻘﺎر واﻷﻏﻨﺎم اﻟﻤﺼﺎﺑﺔ 
  . ﺑﺎﻟﺘﻬﺎب اﻟﻀﺮع
 ﻭ  )succocolyhpatS( ﺇﺳﺘﺎﻓﻴﻠﻮﻛﻮﻛﺲ : ﺑﻜﺘﲑﻳﺎ ﺗﻨﺘﻤﻲ ﺇﱃ ﺃﻧﻮﺍﻉﻭﻗﺪ ﰎﹼ ﻋﺰﻝ ﻣﺎﺋﺔ ﻭﺛﻼﺙ ﻭﲬﺴﻮﻥ  
 ﻭ  )sullicaB( ﻭ ﺑﺎﺳﻴﻠﺲ  )airetcabenyroC(  ﻭﻛﻮﺭﺍﻳﻨﻴﺒﺎﻛﺘﲑﻳﺎ )succocotpertS(ﺇﺳﺘﺮﺑﺘﻮﻛﻮﻛﺲ 
 . )sanomoduesP( ﻭ ﺳﻮﺩﻭﻣﻮﻧﺎﺱ  )alleisbelK( ﻭ ﻛﻠﻴﺒﺴﻴﻠﻼ  )iloc.E(ﺇﻯ ﻛﻮﻻﻯ 
  :  ﺍﳌﻌﺰﻭﻟﺔ ﰲ ﻫﺬﻩ ﺍﻟﺪﺭﺍﺳﺔ ﺗﻨﺘﻤﻲ ﺇﱃ ﺍﻷﻧﻮﺍﻉ ﺍﻟﺘﺎﻟﻴﺔ )succocolyhpatS(ﺑﻜﺘﲑﻳﺎ ﺍﻹﺳﺘﺎﻓﻴﻠﻮﻛﻮﻛﺲ  
 suerua succocolyhpatS ﺇﺳﺘﺎﻓﻴﻠﻮﻛﻮﻛﺲ ﺍﻭﺭﻳﺲ
 inihpled succocolyhpatS ﺇﺳﺘﺎﻓﻴﻠﻮﻛﻮﻛﺲ ﺩﻭﻟﻔﻴﲎ
 suidemretni succocolyhpatS ﺇﺳﺘﺎﻓﻴﻠﻮﻛﻮﻛﺲ ﺇﻧﺘﲑﻣﻴﺪﻳﺎﺯ
  sucityloesac succocolyhpatS  ﻳﻮﻟﻴﺘﻴﻜﺲﺰﺇﺳﺘﺎﻓﻴﻠﻮﻛﻮﻛﺲ ﻛﻴ
 iruics succocolyhpatS  ﻴﻠﻮﻛﻮﻛﺲ ﺳﻜﻴﻮﺭﻯﺇﺳﺘﺎﻓ
 sidimredipe succocolyhpatS ﺇﺳﺘﺎﻓﻴﻠﻮﻛﻮﻛﺲ ﺇﺑﻴﺪﻳﺮﻣﻴﺪﺯ
ﻓﻲ هﺬﻩ اﻟﺪراﺳﺔ ﺗّﻢ إﺟﺮاء اﺧﺘﺒﺎر اﻟﺤﺴﺎﺳﻴﺔ ﻟﺜﻤﺎن وﺗﺴﻌﻮن ﻋﺰﻟﺔ ﻹﺣﺪى وﻋﺸﺮون ﻣﻀﺎدا ً
ﻨﺲ وﻗﺪ ُﻟﻮﺣﻈﺖ   ﻣﻘﺎوﻣﺔ ﻋﺎﻟﻴﺔ ﻣﻦ اﻟﺒﻜﺘﻴﺮﻳﺎ ﻟﻠﻤﻀﺎدات اﻟﺤﻴﻮﻳﺔ اﻟﻤﺨﺘﻠﻔﺔ، ﻓﻘﺪ ُوﺟﺪ أن ﺟ. ﺣﻴﻮﻳًﺎ
وﺟﻨﺲ اﻟﺒﻜﺘﻴﺮﻳﺎ  % ٩٫٢٩ ذو ﻣﻘﺎوﻣﺔ ﻋﺎﻟﻴﺔ ﻟﻸﻣﺒﺴﻠﻴﻦ  succocolyhpatS اﻹﺳﺘﺎﻓﻴﻠﻮآﻮآﺲ
 succocotpertS أﻣﺎ ﺟﻨﺴﻲ اﻹﺳﺘﺮﺑﺘﻮآﻮآﺲ % . ٩٫٨٨اﻟﻤﻌﻮﻳﺔ أﻳﻀًﺎ ﻟﻪ ﻣﻘﺎوﻣﺔ ﻋﺎﻟﻴﺔ ﻟﻸﻣﺒﺴﻠﻴﻦ 
%. ٠٠١ ﻟﻬﻤﺎ ﻣﻘﺎوﻣﺔ آﺎﻣﻠﺔ ﻟﻠﻨﺎﻟﻴﺪﻳﻜﺴﻚ أﺳﻴﺪ واﻟﻤﻴﺜﻴﺴﻠﻴﻦ  airetcabenyroCواﻟﻜﻮراﻳﻨﺒﺎآﺘﻴﺮﻳﺎ 
 ﻟﻬﻤﺎ ﻣﻘﺎوﻣﺔ آﺎﻣﻠﺔ ﻟﻠﺒﻨﺴﻠﻴﻦ sanomoduesP ﺟﻨﺴﻲ اﻟﺒﻜﺘﻴﺮﻳﺎ اﻟﻤﻌﻮﻳﺔ واﻟﺴﻮدوﻣﻮﻧﺎس آﺬﻟﻚ
 succocotpertS آﻤﺎ ُوﺟﺪ أن ﺟﻨﺴﻲ اﻹﺳﺘﺎﻓﻴﻠﻮآﻮآﺲ واﻹﺳﺘﺮﺑﺘﻮآﻮآﺲ %. ٠٠١واﻟﻔﺎﻧﻜﻮﻣﺎﻳﺴﻴﻦ 
آﻤﺎ أن ﺟﻨﺲ اﻹﺳﺘﺮﺑﺘﻮآﻮآﺲ . ﻋﻠﻰ اﻟﺘﻮاﻟﻲ% ٧٫٥٨و % ٩٫٧٩ﻟﻬﻤﺎ ﻣﻘﺎوﻣﺔ ﻋﺎﻟﻴﺔ ﻟﻠﺒﻨﺴﻠﻴﻦ 
ﺎوﻣﺔ آﺎﻣﻠﺔ ﻟﻠﻤﻀﺎدات اﻟﺤﻴﻮﻳﺔ اﻟﻜﻮﻟﻴﺴﺘﻴﻦ ﺳﻠﻔﻴﺖ، اﻟﻜﻮﺗﺮﻳﻤﻮآﺰازول،  ﻟﻪ ﻣﻘ succocotpertS
  %. ٠٠١اﻟﻤﻴﺜﻴﺴﻠﻴﻦ واﻟﻜﻠﻨﺪاﻣﺎﻳﺴﻴﻦ 
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INTRODUCTION 
 
Antibiotic drug-resistance is worldwide problem. Drug resistance 
is now very wide spread, and strains are commonly encountered that 
are resistant to more than one drug (Carter, 1985). Bacteria can 
acquire resistance to antibiotics as a result of chromosomal mutation, 
expression of a latent chromosomal gene, by exchange of genetic 
material through transformation, transduction, or conjugation by 
plasmids (Neu, 1992). Resistant mutants may emerge during treatment. 
The occurrence and establishment of resistant mutants vary with 
different drugs. Selection of mutants is favored by under dosage, 
prolonged administration and the presence of a closed focus of 
infection such as is found in abscesses (Carter, 1985). Bacteria that are 
resistant to as many as ten or more antimicrobial agents have been 
reported (Jacoby, 1991). These highly multi-resistance bacteria were 
made many currently available antimicrobial drugs ineffective and in 
certain instances were already posing important public health problem 
 (Cohn, 1992).  
In the Sudan and other developing countries prescription of 
antibiotics by physicians based mainly on clinical diagnosis. This may 
lead to prescription of wrong antibiotic and also may result in 
emerging of resistance bacterial strains. Moreover, the overuse and 
misuse of antibiotics by public who can purchase easily antibiotic from 
pharmacy without prescription make the condition worst. Now many 
antibiotics are less effective in compacting bacterial infection in the 
Sudan.  
 This study is intended to examine the spread of antibiotic resistance 
of bacteria isolated from human and animal sources in Khartoum State.  
 
 CHAPTER ONE 
1. LITREATURE REVIEW 
1.1 Antibiotics 
1.1.1 Definition and characteristics  
          An organism protects itself from enemies in various ways. It may 
produce metabolic waste products, which change the conditions in medium, 
such as pH, osmotic pressure and surface tension making the environment 
unfavorable to the growth of less tolerant organisms. It may elaborate 
specific toxic substances, which interfere with the metabolism of other 
organism to such an extent that they are either killed or prevented from 
multiplying. These specific toxic substances are called antibiotics (Salle, 
1971). Heritage, Evans and Killington (1996) defined an Antibiotic as a 
substance that was produced by microorganism that in very low 
concentration inhibits or kills the growth of another microorganism 
1.1.2 History and discovery of antibiotics  
 Pasteur and Joubert (1877) noted that a culture of anthrax bacilli was 
killed if it was contaminated by common air-borne organisms. They 
realized that a phenomenon of this kind might well have therapeutic 
possibilities (Thomas, 1993).  
  On an agar plate culture of Staphylococcus aureus, Fleming (1929) 
obtained a mold contaminant that produced a green pigment and prevented 
bacterial growth for some distance around it. He cultivated the mold in a 
liquid medium and found that a filtrate of the culture had the power, even 
when greatly diluted to prevent growth of a number of Gram-positive 
pathogenic bacteria. Since the mold proved to be a species of penicillium, 
he named the antibiotic penicillin. A crude preparation of penicillin was 
subsequently shown to be more effective against a number of infections 
than the sulpha drugs. The antibiotic was found to be so nontoxic that 
amounts beyond the effective curative dose could be safely administered 
(Salle, 1971). 
 In 1940, Chain, Florey, and their co-workers at Oxford succeeded in 
obtaining penicillin preparations of high antibacterial activity. These 
preparations were highly effective in controlling experimental infections in 
animals. The remarkable clinical potentialities of penicillin were quickly 
demonstrated (Thomas, 1993).  
          Dubos (1939) isolated from soil a spore-producing bacillus that was 
capable of destroying living Gram-positive cocci, the organism was found 
to be Bacillus brevis a large Gram-positive rod similar to Bacillus subtilis. 
 He named the antibiotic gramicidin (Salle, 1971).  
 Most antibiotics are produced by Streptomyces. A few are produced 
by Bacillus spp., actinomycetes and fungi. Several antibiotics are semi-
synthetic in origin, e.g. cloxacillin and ampicillin are prepared from 
naturally produced 6-aminopenicillanic acid (Thomas, 1993).  
          Thousands of antibiotics have been isolated and studied. Some are 
useful clinically; others are not satisfactory for clinical application but more 
useful for other purposes.                          
          The field of antibiotics offers unlimited possibilities in medicine. 
Powerful antibiotics, such as penicillin, have proven to be of such 
tremendous importance that an ever-increasing search is going on in the 
hope that agents superior to those now in existence might be isolated (Salle, 
1971).  
1.1.3 Classification and mechanism of action  
Since antibiotics were first discovered in the 1920s, much knowledge 
has been acquired on their mode of action and the significance of this action 
on their relative merits in the therapy of man and animals.  
 Antibacterial agents can be divided into four groups as they affect the 
synthesis of nucleic acid, protein, the formation of the cell wall and 
 permeability of cell membrane. 
1.1.3.1 Nucleic acid inhibitors  
Replication of the nucleic acids of the bacterial cell is prevented 
directly by nalidixic acid and rifamycin and indirectly by the 
sulphonamides. Sulphonamides ultimately deprive the cell of nucleic acid 
and the presence of nalidixic acid prevents its replication.  
 Sulphonamides were interfered with folic acid pathway by binding 
the enzyme dihydropteroate synthase (Forbes et al., 1998). Bacteria to 
produce precursors important for DNA synthesis used the folic acid 
pathway. Sulphonamides target and bind to one of the enzymes, 
dihydropteroate synthase, and disrupt the folic acid pathway (Forbes et al., 
1998).  
 Rifampicin was derivative of the rifamycin family of antibiotics and 
was mainly active against Gram-positive organisms (Thomas, 1993). 
Rifampin inhibited bacterial growth by binding strongly to the DNA-
dependant RNA polymerase of bacteria. Thus, it inhibit bacterial RNA 
synthesis (Jawetz et al., 1989). 
Quinolones inhibited bacterial DNA gyrases (topoisomerases) which 
was catalyzed supercoiling of bacterial DNA (Thomas, 1993).    
 1.1.3.2 Protein synthesis inhibitors    
Antibiotic classes that act by inhibiting protein synthesis include 
aminoglycosides e.g. gentamicin, tobramycin, kanamycin and streptomycin, 
tetracycline, chloramphenicol, macrolides, e.g. erythromycin and 
azithromycin, and lincosamides, e.g. clindamycin (Forbes et al., 1998; 
Cheesbrough, 2000).  
 Aminoglycosides inhibit bacterial protein synthesis by binding to 
protein receptors on the organism's 30S ribosomal subunit. This process 
interrupts several steps, including initial formation of the protein synthesis 
complex, accurate reading of the mRNA code, and disruption of the 
ribosomal – mRNA complex (Baker and Breach, 1980; Forbes et al., 1998).  
Macrolides (erythromycin and azithromycin) bind to the 50S subunit 
of the ribosome and the binding site is a 23S rRNA (Jawetz et al., 1989).  
 Chloramphenicol inhibits the addition of new amino acids to the 
growing peptide chain by binding to the 50S ribosomal subunit (Jawetz et 
al., 1989). This antibiotic is highly active against a wide variety of Gram-
negative and Gram-positive bacteria (Forbes et al., 1998).  
Tetracyclines inhibit protein synthesis by binding to the 30S 
ribosomal subunit so that incoming tRNA-amino acid complexes cannot 
 bind to the ribosome, thus halting peptide chain elongation. Tetracycline’s 
have a broad spectrum of activity that includes Gram-negative bacteria, 
Gram-positive bacteria, and several intracellular bacterial pathogens such as 
chlamydia and rickettsia (Forbes et al., 1998). 
         Lincosamides (clindamycin) inhibit protein synthesis by binding to 
receptors on the bacterial 50S ribosomal subunit and subsequent disruption 
of the growing peptide chain. Primarily because of uptake difficulties 
associated with Gram-negative outer membranes, the macrolides and 
clindamycin generally are not effective against most genera of Gram-
negative bacteria. However, they are effective against Gram-positive 
bacteria (Forbes et al., 1998).  
1.1.3.3 Cell wall synthesis inhibitors   
The bacterial cell wall known as the peptidoglycan, or murein layer, 
plays an essential role in the life of the bacterial cell. The cell wall of 
bacteria is tough and rigid and lies external to the cell membrane, giving the 
whole cell protection from possible osmotic damage (Forbes et al., 1998). 
Several agents affect cell wall synthesis, the most important being 
penicillin’s e.g. cloxacillin, ampicillin and amoxycillin, cephalosporins e.g. 
cephradine, cefuroxime and ceftazidime and glycopeptides e.g. vancomycin 
 (Cheesbrough, 2000). 
 Beta-lactam antimicrobial agents are those that contain the four-
membered, nitrogen-containing, beta lactam ring at the core of their 
structure, and mode of action of these drugs that target and inhibit cell wall 
synthesis by binding the enzymes involved in synthesis (Forbes et al., 
1998). 
 Glycopeptides which are the other major class of antibiotics that 
inhibit bacterial cell wall synthesis e.g. vancomycin. Vancomycin is the 
most commonly used agent in this class inhibits cell wall synthesis by 
binding to precursors of cell wall synthesis (Forbes et al., 1998). 
Vancomycin can not penetrate the outer membrane of most Gram-negative 
bacteria to reach their cell wall precursor targets, because of its relatively 
large size. Therefore, this agent is usually ineffective against Gram-negative 
bacteria (Forbes et al., 1998).  
 Some fungi of Cephalosporium spp yield antimicrobial substances 
called cephalosporins (Jawetz et al., 1989).  
Cephalosporins consisted of three generations first one were cephradine and 
cephalothin, second was cefuroxime and third were ceftazidime and cefotaxime 
(Jawetz et al., 1989; Cheesbrough, 2000).  
The mechanism of action of cephalosporins is analogous to that of penicillin's by 
binding to specific PBPs that serve as drug receptors on bacteria; inhibiting cell wall 
synthesis by blocking the transpeptidation of peptidoglycan; and activating autolytic 
 enzymes in the cell wall that can produce lesions resulting in bacterial death (Jawetz 
et al., 1989). 
1.1.3.4 Cell membrane function inhibitors  
Polymyxins (polymyxin B and colistin) are the agents most 
commonly used that disrupt bacterial cell membranes. Most notably, they 
are more active against Gram-negative bacteria, while activity against 
Gram-positive bacteria tends to be poor (Forbes et al., 1998). Polymyxin 
becomes firmly bound to the cytoplasmic membrane and acts by damaging 
this structure (Thomas, 1993).  
1.1.4 Toxicity and side effects  
Not all antimicrobials, at the concentration required to be effective 
are completely non-toxic to human cells. Most, however, show sufficient 
selective toxicity to be of value in the treatment of microbial disease 
(Cheesbrough, 2000). Most serious side effects of penicillin are due to 
hypersensitivity. The tetracycline and chloramphenicol produce varying 
degrees of gastrointestinal upset (nausea, vomiting, and diarrhea). 
Gentamicin was toxic, particularly in the presence of impaired renal 
function. Fever, skin rashes and other allergic manifestations may result 
from hypersensitivity to streptomycin (Jawetz et al., 1989).  
1.1.5 Antibiotics spectrum  
 1.1.5.1 Broad spectrum antibiotics 
The term broad spectrum is applied to antibacterial agents with 
activity against a wide range of Gram-positive and Gram-negative 
organisms such as tetracyclines, aminoglycosides, sulphonamides and 
chloramphenicol (Thomas, 1993; Cheesbrough, 2000). 
1.1.5.2 Narrow spectrum antibiotics  
Narrow spectrum antibiotics are those with activity against one or 
few types of bacteria, e.g. vancomycin against staphylococci and 
enterococci (Cheesbrough, 2000).  
1.1.6 Type of action 
Antimicrobial agents are generally described as bacteristatic when, at 
usual dosage, they prevent the active multiplication of bacteria, e.g. 
chloramphenicol, tetracycline and erythromycin, and are described as 
bactericidal when, at usual dosage, they kill bacteria, e.g. the penicillin’s, 
cephalosporins, glycopeptides and aminoglycosides (Cheesbrough, 2000). 
Some bacteristatic agents become bactericidal when used at higher 
concentrations e.g. erythromycin and tetracycline (Thomas, 1993; 
Cheesbrough, 2000). 
1.1.7 Clinical use of antibiotics  
 The object of antibiotic therapy is to cure the patient with the 
minimum of complications and discomfort. At the same time, it is important 
to discourage the emergence of drug-resistant organisms. The principles 
should observed are, antibiotics should not be given for trivial infections 
they should be used for prophylaxis only in special circumstances, 
treatment should be based on a clear clinical and bacteriological diagnosis, 
the choice of antibiotic is essentially a clinical matter. Antibiotics for 
systemic treatment should be given in full therapeutic doses for an adequate 
period. In local treatment of superficial infections it is important to use 
either antiseptics or antibiotics which are rarely or never used 
systematically, e.g. mupirocin, bacitracin and polymyxin. Antibiotic 
solutions and powders should not be liberated into the environment. They 
can cause hypersensitivity reactions and encourage development of 
antibiotic – resistant strains (Thomas, 1993).  
 1.1.8 Combination of antibiotics  
Occasionally, a combinations of antimicrobials were used to treat 
mixed infections, to prevent treatment failure and drug resistance from 
developing, to treat severe infection when the organism is not known, or 
when it was necessary to obtain a greater antimicrobial effect from two 
bactericidal drugs acting together (synergistic effect) (Cheesbrough. 2000).  
Baker and Breach (1980) stated that when two bacteristatic 
antibiotics were given together, the resulting action was indifferent, when 
two bactericidal antibiotics were given together, the resulting action was 
synergistic and when a bacteristatic and bactericidal antibiotics were given 
together, the result was antagonistic. Although this is not necessarily true 
with all antibiotics, it is, nevertheless, a good rule to follow, unless tests for 
combined actions have been performed. It must also be noted that a 
combination of two β-lactams does not necessarily produce a synergistic 
effect (Hugo and Russell, 1989).             
1.2 Drug resistance  
If bacteria are repeatedly sub cultured in the presence of gradually 
increasing sub inhibitory concentrations of an antibiotic it is usually 
possible to obtain mutant organisms which will survive and multiply in 
 concentrations which are lethal for the parent strain (Thomas, 1993).  
Antibiotics can be inactivated either by enzymatic cleavage or by 
chemical modification such that they no longer interact with the target site 
or are no longer taken up by the organism rendering them inactivates (Pratt, 
1990; Lancini, 1995). 
  In 1944, most staphylococci were susceptible to penicillin, although a 
few resistant strains had been observed (Jawetz et al., 1989). In 1946, about 
60% of hospital strains isolated in the UK were penicillin-resistant (Barber 
and Rozwadowska-Dowzendo, 1948). After massive use of penicillin, 65-
85% of staphylococci isolated from hospitals in 1948 were β-lactamase 
producers and thus resistant to penicillin G (Jawetz et al., 1989). The 
introduction of streptomycin, tetracycline, chloramphenicol and 
erythromycin for the treatment of infections caused by penicillin-resistant 
staphylococci was similarly followed by the emergence of strains resistant 
to these antibiotics (Shanson, 1981).    
         The degree of resistance and the speed with which it develops varies 
with the organism and the drug. Thus the resistance of Staphylococcus 
aureus to penicillin, chloramphenicol and the tetracyclines usually develops 
slowly in multiple small steps and many successive subcultures may be 
 required before a high level of resistance is obtained. In contrast the 
resistance of various organisms to streptomycin and of Mycobacterium 
tuberculosis to isoniazid often rises suddenly in one step to very high levels 
(Thomas, 1993). While it is possible to select antibiotic-resistant mutants of 
most organisms in vitro, this really reflects the situation in vivo. Thus 
naturally occurring strains of Streptococcus pyogenes have remained fully 
sensitive to penicillin in spite of the widespread use of the drug and it has 
not been possible to obtain resistant strains artificially (Thomas, 1993). 
When antibiotic resistance is found in clinically derived strains of bacteria 
the mechanism of resistance often differs from that obtained by laboratory 
means. For example, penicillin-resistant Staphylococcus aureus 
encountered in hospitals produce penicillinase (β-lactamase) whereas 
resistant mutants selected in the laboratory have a decreased ability to bind 
the drug. Likewise, many of the clinically isolated bacteria resistant to 
aminoglycosides produce plasmid-mediated antibiotic–inactivating 
enzymes, but resistant strains selected in vitro possess mutated ribosomal 
binding sites (Thomas, 1993).  
The ribosome of staphylococci can become insensitive to 
erythromycin following specific enzymatic modifications of rRNA (Davies, 
 1992). Rifampin resistance was resulted from inactivation of a single target 
(Spratt, 1994). 
A third form of antibiotic resistance is known as “drug tolerance”. 
Penicillin-tolerant strains of Staphylococcus aureus are inhibited by low 
concentrations of penicillin but are resistant to the lethal (bactericidal) 
effects of the antibiotic (Thomas, 1993). It has been suggested that tolerant 
organisms are deficient in autolytic enzyme activity, which is necessary for 
cell lysis and the lethal action of penicillin. Penicillin tolerance is also 
common among streptococci, though not Streptococcus pneumoniae 
(Thomas, 1993).  
The development of antibiotic-resistant strains during therapy was 
unlikely to be a serious clinical problem because the fraction of resistant 
cells in bacterial population was always very small (Davies, 1994).  
Drug resistance has increased substantially in recent years and has 
reduced the value of formerly widely prescribed agents such as the 
sulphonamides and ampicillin (Hugo and Russell, 1989).  
1.2.1 Multiple-drug resistance 
 Multiple-drug resistance has been demonstrated in Mycobacterium 
tuberculosis, Streptococcus pneumoniae, Staphylococcus aureus, 
 enterococcus, Shigella dysenteriae, escherichia, Haemophilus influenzae, 
klebsiella, proteus, salmonella, serratia, and pseudomonas (Cohen, 1992).  
Resistant enterobacteriaceae frequently contain multiple plasmids, 
the larger of which can carry genes for resistance to 10 or more 
antimicrobial agents (Jacoby, 1991). These highly resistant bacteria were 
made many currently available antimicrobial drugs ineffective and in 
certain instances were already posing important public health problem 
(Cohen, 1992). Another aspect of multi-resistance was that any one of the 
antimicrobial agents affected can maintain selection for resistance to the 
group as was illustrated by the need to restrict the use of kanamycin and 
tetracycline as well as ampicillin and carbenicillin to rid a burn unit of 
Pseudomonas aeruginosa with plasmids encoding linked resistance to 
carbenicillin, kanamycin and tetracycline (Lowbury, 1972). 
1.2.2 Mechanisms of antibiotics resistance  
Successful bacterial resistance to antimicrobial action requires 
interruption or disturbance of one or more of the steps essential for effective 
antimicrobial action. These disturbances or resistance mechanisms can 
come about in various ways, but the end result is partial or complete loss of 
antibiotic effectiveness. Different aspects concerning antimicrobial 
 resistance mechanisms include biologic vs. clinical antimicrobial resistance, 
environmentally mediated antimicrobial resistance, and microorganism-
mediated antimicrobial resistance (Forbes et al., 1998).  
1.2.2.1 Biologic vs. clinical resistance  
Development of bacterial resistance to antimicrobial agents to which 
they were originally susceptible requires alterations in the cell’s physiology 
or structure. Biologic resistance refers to changes that result in the organism 
being less susceptible to a particular antimicrobial agent than has been 
previously observed. When antimicrobial susceptibility has been lost to 
such an extent that the drug is no longer effective for clinical use the 
organism has achieved clinical resistance (Forbes et al., 1998).  
1.2.2.2 Environmentally mediated antimicrobial resistance 
 Environmentally mediated resistance is defined as resistance that 
directly results from physical or chemical characteristics of the environment 
that either directly alters the antimicrobial agent or alters the 
microorganism’s normal physiologic response to the drug. Examples of 
environmental factors that mediate resistance includes pH, anaerobic 
atmosphere, cation (e.g. Mg++ and Ca++) concentrations, and thymine-
thymidine content (Forbes et al., 1998).  
 1.2.2.3 Microorganism-mediated antimicrobial resistance  
Microorganism-mediated resistance refers to antimicrobial resistance 
that is due to genetically encoded traits of the microorganism and is the type 
of resistance that in vitro susceptibility testing methods are targeted to 
detect (Forbes et al., 1998). Organism-based resistance can be divided into 
two subcategories, intrinsic or inherent resistance and acquired resistance.  
1.2.2.3.1 Intrinsic resistance 
Intrinsic resistance is antimicrobial resistance resulting from the 
normal genetic, structural, or physiological state of microorganism (Forbes 
et al., 1998). Such resistance is considered to be natural and consistently 
inherited characteristic that is associated with the vast majority of strains 
that constitute either a particular bacterial group, genus or species. 
Therefore, this is predictable resistance so that once the identity of the 
organism is known, so are certain aspects of its antimicrobial resistance 
profile (Forbes et al., 1998). 
1.2.2.3.2 Acquired resistance  
 Bacteria can acquire resistance to antibiotics as a result of a 
chromosomal mutation, expression of a latent chromosomal gene, by 
exchange of genetic material through transformation (the exchange of 
 DNA), transduction (bacteriophage), or conjugation by plasmids (extra 
chromosomal DNA) (Neu, 1992). 
Acquired resistant was usually reversible. However, the ease with 
which resistance reverts to sensitivity depends upon a number of factors 
such as nature of the organism, nature of the drug, degree of resistance that 
has been established, and whether the resistance has been acquired by 
genetic or phenotypic adaptation (Salle, 1971). It was antibiotic resistance 
that results from altered cellular physiology and structure caused by 
changes in microorganism’s usual genetic makeup (Forbes et al., 1998).   
The basic mechanisms of acquired microbial resistance to 
antimicrobial agents were generally divided into five categories, the 
development of an altered drug target; a decrease in the concentration of 
drug that reaches the receptors by altered rates of entry or removal of the 
drug; degradation of the antibiotic; synthesis of resistant, or alternate 
metabolic pathways that were no longer susceptible to an antibiotic; and 
failure to metabolize the drug to its active state (Neu, 1992;Davies, 1992; 
Spratt, 1994; Brody, 1994).    
1.2.3 Common pathways for antimicrobial resistance  
Whether resistance is intrinsic or acquired, bacteria share similar 
 pathways or strategies to affect resistance to antimicrobial agents. The 
pathways involve enzymatic destruction or alteration of the antibiotic, 
decreased intracellular uptake or accumulation of drug and altered antibiotic 
target are the most common (Davies, 1994; Forbes et al., 1998).  
Based on their reaction to staining protocol, bacteria were divided 
into Gram-negative and Gram-positive classifications. Gram-positive 
bacteria were surrounded by a thick, rigid, porous cell wall composed of 
peptidoglycans. It offers little resistance to the diffusion of small molecules 
such as antibiotics. Gram-negative bacteria have an additional outer 
membrane composed of lipopolysaccharide that was located around the 
cytoplasmic membrane and the thin peptidoglycan layer (Brody, 1994). 
1.2.3.1 Resistance to beta-lactam antibiotics  
Bacterial resistance to beta–lactams may be mediated by enzymatic 
destruction of the antibiotics, altered antibiotic targets, or decreased 
intracellular uptake of the drug (Forbes et al., 1998). 
 Staphylococci are the Gram-positive bacteria that most commonly 
produced β-lactamase; approximately 90% or more of clinical isolates are 
resistant to penicillin as a result of enzyme production (Forbes et al., 1998). 
Rare isolates of enterococci also produce β-lactamase.  
  Gram-negative bacteria, including enterobacteriaceae, P. aeruginosa, 
H. influenzae and N. gonorrhoeae, produce dozens of different β-lactamase 
types that mediate resistance to one or more of the β-lactam antibiotics 
(Forbes et al., 1998). Enzyme inactivation of the drug was one of the most 
common biochemical processes that engender resistance to a variety of 
antibiotic structural types in bacteria (Jacoby, 1991). If a drug acts by 
inhibiting an enzyme that was critical for cell growth, then cells that 
produce greater amounts of the enzyme may be able to produce a sufficient 
amount of the metabolic product to survive in the presence of the drug 
concentrations that are usually attained in clinical treatment (Pratt, 1990). 
1.2.3.2 Resistance to glycopeptides  
The acquired resistance to vancomycin has been described for 
enterococci but not for staphylococci or streptococci. The mechanism 
involves the production of altered cell wall precursors that do not bind 
vancomycin with sufficient avidity to allow inhibition of peptidoglycan 
synthesizing enzymes (Forbes et al., 1998). 
Vancomycin is the only cell wall inhibiting agent for use against β-
lactams methicillin-resistant staphylococci and ampicillin-resistant 
enterococci (Forbes et al., 1998). 
 1.2.3.3 Resistance to aminoglycosides  
Resistance to the aminoglycosides gentamicin emerged after some 
ten years use and was associated with its extensive use as a topical 
antibiotic (Noble and Naidoo, 1978). 
          Resistance to streptomycin produced by a chromosomal mutation was 
due to an alteration in the ribosome so that streptomycin could no longer 
bind to the ribosome (Lacey and Chopra, 1972). Plasmid-borne resistance to 
streptomycin was achieved by different mechanisms; it encodes an enzyme 
which modifies streptomycin so that it can no longer bind to the ribosome 
(Grinsted and Lacey, 1973).    
         Analogous to β-lactam resistance, aminoglycoside resistance is 
accomplished by enzymatic, altered target, or decreased uptake pathways. 
Several different aminoglycoside-modifying enzymes are produced by 
Gram-positive and Gram-negative bacteria (Forbes et al., 1998). 
 Aminoglycosides enter the Gram-negative cell by passing through 
outer membrane porin channels. Therefore, porin alterations may also 
contribute to aminoglycoside resistance among these bacteria (Forbes et al., 
1998). 
 
 1.2.3.4 Resistance to tetracyclines  
 Tet M, a gene that confers tetracycline resistance, was particularly 
common, and was identified in staphylococci, streptococci and enterococci 
(Roberts, 1990).  
1.2.3.5 Resistance to quinolones  
Resistance to quinolones is most frequently mediated by either 
decreased uptake or accumulation or by production of an altered target. 
Components of the Gram-negative cellular envelope can limit quinolones 
access to the cell’s interior site of DNA processing (Forbes et al., 1998). 
1.2.4 Emergence and dissemination of antimicrobial resistance  
  The known resistance pathways are not necessarily new mechanisms 
that have recently evolved among bacteria. By definition, antibiotics 
originate from microorganisms and kill or inhibit growth of another. 
Therefore, antibiotic resistance mechanisms always have been part of the 
evolution of bacteria as a means of survival among antibiotic-producing 
competitors (Forbes et al., 1998). 
        However, with the introduction of antibiotics into medical practice, 
clinically relevant bacteria have had to adopt resistance mechanisms as part 
of their survival strategy. With our use and abuse of antimicrobial agents, a 
survival of the fittest strategy has been used by bacteria to adapt to the 
 pressures of antimicrobial attack (Forbes et al., 1998). 
       All bacteria resistance strategies are encoded by one or more genes and 
these resistance genes are readily shared between strains of the same 
species, between species of different genera, and even between more 
distantly related bacteria. When a resistance mechanism arises, either by 
mutation or gene transfer, in a particular bacterial strains or species, there is 
a propensity for this mechanism to then be passed on to other organisms 
using commonly described paths of genetic communication. Therefore, 
resistance may spread to a wide variety of clinically important bacteria, and 
any single organism can acquire multiple genes and become resistant to the 
full spectrum of available antimicrobial agents (Forbes et al., 1998). For 
example, there already exists a strain of enterococci and Pseudomonas 
aeruginosa for which no effective therapy is currently available. 
Alternatively, multiple resistances may be mediated by a gene that encodes 
for a single very potent resistance mechanism. One such example is the 
mecA gene that encodes staphylococcal resistance to methicillin and to all 
other β-lactams currently available for use against these organisms, leaving 
vancomycin as the single available and effective cell wall-inhibiting agent 
(Forbes et al., 1998). 
 1.3 Mutation 
Mutation in chemical terms means an alternative in the base pair 
sequence of the DNA double helix. This may be due to substitution of one 
base for another, deletion of bases or insertion of new bases (Salle, 1971; 
Thomas, 1993). Every mutation is due to a change in the structure of a gene 
(Thomas, 1993).  
Smooth – rough (S – R) variation is one of the most obvious and 
important types of mutation shown by pathogenic bacteria (Thomas, 1993). 
The variation, involves a change of colonial appearance from smooth to 
rough, a loss of surface components (somatic and capsular antigens) and a 
loss or diminution of virulence. It commonly occurs when bacteria are 
grown for long periods on artificial media (Thomas, 1993).  
In studies of molecular evolutionary biology, the term mutation rate 
is applied to estimations of the rate (per generation) of mutation per 
nucleotide, per locus, or eventually for the whole genome and selectivity 
favourable, unfavourable, or neutral mutations are considered (Martinez, 
and Baquero, 2000). Martinez and Baquero (2000) stated that the mutation 
rate is not a simple characteristic of a specific bacterial species – antibiotic 
association. On the contrary, the probability of the emergence of antibiotic-
 resistant mutants is a complex phenomenon, as previously recognized by 
others, in which the physiology, the genetics, the antibiotic-bacterium 
dynamics, and the historical behavior of bacterial populations, together with 
the physical structure of the selective medium, play major roles. Martinez 
and Baquero (2000) assumed that the mutation rate determined under 
conventional laboratory conditions probably differs greatly from that in vivo 
at the site of infection.  
  The mutation rate varies with different properties and different 
bacteria, but it is commonly between 1 in 107 and 1 in 1010. These rates are 
for a single property. The total number of mutants, involving a variety of 
properties, is far greater (Thomas, 1993).  
Mutagenic agents, such as x-rays, ultraviolet light and alkylating agents, cause a 
general increase in the rates of mutation (Thomas, 1993).  
1.3.1 Factors affecting mutations rates  
The cell machinery responsible for replication of DNA is extremely 
efficient, and under normal conditions only rarely is a “wrong” base 
incorporated into a gene (Salle, 1971). The spontaneous mutation rate can 
be greatly increased, however, by treating bacteria with mutagenic agents. 
Induced mutants occur at rates from 10 to 100.000 times more frequently 
than spontaneously occurring mutants among bacteria that have been 
 exposed to mutagenic agents (Salle, 1971). Mutagenic agents exert their 
effect by reacting, directly or indirectly, with DNA. Agents which have 
proved effective mutagenes include ultraviolet light, x-rays, carcinogenic 
chemicals such as nitrogen and sulphur mustards, various peroxides and 
epoxides, and purine and pyrimidine analogous (Salle, 1971). Some 
mutagenes such as nitrous acid and hydroxylamine have been shown to 
cause mutations in vitro by allowing them to react with purified 
transforming DNA and then introducing the altered DNA into recipient 
bacteria (Salle, 1971).  
1.3.2 Transformation  
Transformation is the movement of small pieces of DNA from the 
environment into the bacterial chromosome (Pratt, 1990). 
 In the 1928 Griffith discovered the transformation of a rough (R) 
non-capsulated strain of Streptococcus pneumoniae into a smooth (S) 
capsulated strain (Salle, 1971; Thomas, 1993). He injected mouse with a 
mixture containing a few living rough pneumococci derived from a type II 
rough cells (Type II-R) and a large number of heat-killed type III smooth 
cells (SIII). The mouse subsequently died, and living type III smooth (Type 
III-S) pneumococci could be isolated from it. As later found, this type 
 transformation resulted from the uptake by the living type II rough (Type II-
R) bacteria of DNA released from the heat-killed type III-S pneumococci. 
Drug resistance and other properties can also be transferred by means of 
free DNA (Salle, 1971).  
1.3.3 Transduction  
Transduction is the transfer of DNA from a donor cell to recipient 
cell by bacteriophage (Salle, 1971; Lacey, 1975; Lancini, 1995). Zinder and 
Lederberg (1952) stated that two kinds of transduction can be distinguished, 
a non-specific transduction which can transfer any part of the host DNA, 
and specific transduction which is restricted to transfer a specific DNA 
segments.  
In 1975, Lacey wrote that transduction was of considerable clinical 
importance, particularly among the Gram-positive bacteria. The great 
majority of the penicillin-resistant staphylococci, for example, acquired the 
genes for β-lactamase via phage-mediated transduction (Pratt, 1990).  
 Transduction occurs when a phage incorporates part of the genetic 
material of a host bacterium and carries it to another bacterium (Thomas, 
1993). Thus resistance to various antibiotics can be transduced in certain 
sensitive strains of Staphylococcus aureus also certain antigenic and 
 biochemical properties can be transduced between closely related strains of 
salmonellae (Thomas, 1993).  
 Transduction may be more important in spreading resistance among 
Gram-positive bacteria than among Gram-negative cells (Hugo and Russell, 
1989). 
1.3.4 Conjugation  
 Bacterial conjugation was discovered by J. Lederberg in the late 
1940s (Hugo and Russell, 1989).  
Conjugation is the transfer for genetic material from cell to cell by 
direct contact. Sexual conjugation in bacteria was first demonstrated by 
Lederberg and Tatum in 1946 using mutants of Escherichia coli K-12 
especially derived for this purpose (Salle, 1971). In bacterial conjugation 
direct contact occurs between two sexually differentiated cells, and one of 
these, the donor (male F+), directly transfers chromosomal DNA to other, 
the recipient (female F⎯ ) (Salle, 1971). 
1.3.5 Plasmids    
 Plasmids are extra chromosomal DNA elements. The transmission of 
resistance to antibiotics, often to several drugs simultaneously, from one 
bacterium to another was attributed to ‛R factors’, or plasmids, which were 
 small self-replicating double-stranded DNA circles, which were 
independent of the chromosome (Williams, 1996).  
The ability to transfer genes that confer drug resistance by cellular 
conjugation is due to the presence in the bacterial cell of DNA elements, 
known as plasmids that replicate separately from, but usually under the 
control of, the bacterial chromosome (Hugo and Russell, 1989).   
Indeed it is now generally accepted that plasmids play a major role in 
the mediation and transfer of antimicrobial resistance among the 
staphylococcal population (Lacey, 1975). Plasmids may be the vectors of 
the resistance genes, or the genes may themselves be located on discrete 
movable DNA elements, called transposons (Masaudi et al., 1990; Neu, 
1992). A plasmid was recognized in E.coli confers resistance to ampicillin, 
chloramphenicol, kanamycin, streptomycin and sulphonamides (Vila, 
1998).   
1.3.5.1 Resistance plasmids  
Resistant (R) plasmids were large may contain multiple resistance 
genes and were self-transmissible through conjugation. The R plasmids 
were smaller, do not contain the genes for conjugative transfer and usually 
encode for resistance to a single antibiotic (Pratt, 1990). Some R plasmids 
 confer to up to eight different antibiotics. The R plasmids were found in a 
wide variety of bacteria, but they were particularly important in 
staphylococci and other Gram-positive bacteria, in which they were 
responsible for most or all of the plasmid-mediated drug resistance (Pratt, 
1990). From an epidemiological point of view, plasmid resistance was most 
important, since resistance in this form was transmissible and may be 
associated with other properties that enable a microorganism to colonize 
and invade a susceptible host (Brody, 1994). The wide spread use of 
antibiotic therapy, especially in hospitals, has led to the spread of R-
plasmids among pathogenic bacteria.  
Not all-antibacterial drug-resistance properties of cells can be 
attributed to genes carried by plasmids. Drug-resistance genes may also be 
chromosomally determined, in which case transfer, if it occurs at all, was 
mediated by a transducing phage or by F+ plasmid-facilitated chromosome 
transfer (Thomas, 1993).  
 
 
 
 CHAPTER TWO 
2. MATERIALS AND METHODS 
2.1 Sterilization 
2.1.1 Sterilization of equipments  
Petri dishes, test tubes, forceps, flasks, Pasteur pipettes and graduated 
pipettes and greases, oils and lubricants such as liquid paraffin and glycerol 
were sterilized in a hot air oven at 160ºC for one hour or 180ºC for half an 
hour.  
Bottles and plastic containers were sterilized by autoclaving at 121ºC 
(15 Ib/inch2) for 15 minutes. 
Wire loops were sterilized by heating in a flame. 
2.1.2 Sterilization of culture media and solutions   
          Media and solutions were sterilized by autoclaving at 121ºC (15 
Ib/inch2) for 15 minutes. 
Carbohydrate media were sterilized by autoclaving at 110ºC for 10 
minutes. 
2.2 REAGENTS 
2.2.1 Hydrogen peroxide 
  This was prepared in a concentration of 3% aqueous solution and it 
 was used for catalase test and obtained from Agropharm Ltd., Buckingham. 
2.2.2 Tetra methyl -P-phenylenediamine dihydrochloride  
This reagent was used for oxidase test; it was prepared as 1% 
aqueous solution. 
2.2.3 Alpha-naphthol solution  
Alpha-naphthol was obtained from BDH Ltd. This reagent was 
prepared as 5% aqueous solution for Voges-Proskaüer (VP) test. 
2.2.4 Potassium hydroxide 
 It was used for Voges-Proskaüer test and was prepared according to 
Barrow and Feltham (1993) as 40% aqueous solution. 
2.2.5 Methyl red 
 It was prepared by dissolving methyl red (0.04g) in ethanol (40ml). 
The volume was completed to 100ml with distilled water. It was used for 
methyl red test. 
2.2.6 Nitrate test reagent 
Nitrate test reagent was consisting of two solutions and they were 
prepared according to Barrow and Feltham (1993). Solution A was 
consisting of 0.33% sulphanilic acid dissolved by gentle heating in 5N-
acetic acid. Solution B was consisting of 0.6% dimethyl-α-naphthylamine 
 dissolved by gentle heating in 5N-acetic acid. 
2.2.7 Kovac’s reagent  
This reagent consisted of 5g P-dimethylaminobenzaldehyde, 75ml 
amyl alcohol and 25ml concentrated hydrochloric acid. It was prepared 
according to Barrow and Feltham (1993) by dissolving the aldehyde in the 
alcohol by heating in water bath. Then it was cooled and the acid was 
added. The reagent was used for indole test and was stored at 4˚C. 
2.3 Indicators 
2.3.1 Andrade’s indicator 
   This was prepared according to Barrow and Feltham (1993) by 
dissolving 5grams of acid fuchsin in one litre of distilled water and 150ml 
alkali solution was added, mixed and was allowed to stand at room 
temperature for 24h with frequent shaking until the colour become brown. It 
was used in peptone water sugar medium. 
2.3.2 Phenol red  
    Phenol red was obtained from Hopkins and Williams Ltd. It was used 
for urea agar base medium. It was prepared as 0.2% solution. 
2.3.3 Neutral red  
          Neutral red was used for adjusting the pH. It was product of Hopkins 
 and William Ltd. London. 
2.3.4 Bromothymol blue 
This solution was prepared by dissolving 0.2g of the bromothymol 
blue powder (BDH Ltd.) in 100ml distilled water. 
2.4 Blood  
 Defibrinated sheep blood was used in preparing blood agar medium. 
It was collected from jugular vein in sterile flask containing glass beads and 
was mixed gently. The blood was distributed in 10ml amount in sterile 
screw capped bottles and stored in refrigerator.    
2.5 Media  
   Different types of media including solid, semisolid and liquid media 
were used for isolation and identification of bacteria in this study.  
2.5.1 Solid media 
2.5.1.1 Nutrient agar medium  
This medium was obtained from Oxoid Ltd. It consists of yeast 
extract, sodium chloride, peptone and agar (2%). It was prepared according 
to manufacturer's instructions by dissolving twenty-eight grams of the 
powder in one litre of distilled water by boiling. The pH was adjusted to 7.4 
and then the medium was sterilized by autoclaving at 121ºC for 15 minutes, 
 cooled to 50-55ºC and then distributed into sterile Petri dishes in 20ml 
amount and allowed to solidify on leveled surface.  
2.5.1.2 Blood Agar medium   
  Hundred ml of fresh defibrinated sheep blood were added to 900 ml 
of melted sterile nutrient agar which was cooled to 50˚C then mixed and 
distributed into sterile Petri dishes in 20ml amount and allowed to solidify 
on leveled surface. 
          Another concentration 15% was also used for recognition of the type 
of haemolysis. It was obtained by adding 150ml of fresh defibrinated sheep 
blood to 850ml of melted sterile nutrient agar which was cooled to 50ºC 
then mixed and distributed into sterile Petri dishes in 20ml volume and 
allowed to solidify on leveled surface. 
2.5.1.3 MacConkey's Agar medium 
  Oxoid Ltd. supplied this medium. It consists of peptone, lactose, bile 
salt, sodium chloride, agar, neutral red, and crystal violet. 
The dehydrated medium (51.5g) were suspended in one litre of 
distilled water and brought to the boiling to dissolve completely. The pH 
was adjusted to 7.1±0.2 and the preparation was then sterilized by 
autoclaving at 121ºC for 15 minutes. Then cooled to 45 - 50ºC, distributed 
 into sterile Petri dishes in about 20ml amount and allowed to solidify on 
leveled surface. 
2.5.1.4 Diagnostic Sensitivity Test agar (DST) medium  
This medium was supplied by Difco (Ltd.). It consists of protease 
peptone, veal infusion solids, dextrose, sodium chloride, disodium 
phosphate, sodium acetate, adenine sulphate, guanine hydrochloride, uracil, 
xanthine and Ion agar No. 2.  
          Forty grams of the medium were dissolved completely by boiling in 
one litre of distilled water. The pH was adjusted to 7.3. Then sterilized by 
autoclaving at 121ºC for 15 minutes. Then cooled to 45 -50ºC, distributed 
into sterile Petri dishes in about 20ml amount and allowed to solidify at 
room temperature on leveled surface. 
2.5.1.5 Urea agar medium  
It consists of peptone, dextrose, sodium chloride disodium phosphate, 
phenol red and agar.  
 An amount of 2.4 grams of powder were suspended in 95 ml of 
distilled water and steamed to dissolve completely. The pH was adjusted to 
6.8 and then sterilized by autoclaving at 115ºC (10 Ib/inch2) for 20 minutes 
and then cooled to 50ºC.  Five ml of sterile 40% urea solution (Oxoid Ltd.) 
 were added aseptically, mixed well and then distributed as 5ml amounts 
into sterile bottles and were allowed to set in the slope position.  
2.5.1.6 Aesculin-bile agar medium 
This was prepared according to Swan (1954). It consists of ox bile, 
aesculin, ferric citrate, agar and nutrient broth. All the ingredients except 
aesculin were dissolved in water by heating. The complete medium was 
allowed to cool and then the aesculin was added, distributed in screw-
capped bottles and sterilized by autoclaving at 115ºC for 20 min. Then 
allowed setting in the slope position. 
2.5.1.7 Simmon's citrate medium 
This medium was supplied by Oxoid (Ltd.). It was the modified 
Koser's citrate medium. It consists of NaCl, MgSO4.7H2O, NH4H2PO4, 
K2HPO4, citric acid, distilled water, bromothymol blue and agar. Twenty-
three grams were dissolved in one litre of distilled water and dissolved by 
steaming. The pH was adjusted to 7.0 then sterilized by autoclaving at 
115˚C for 15min. Then it was distributed into sterile MacCarteny bottles 
then allowed to set in a slope position.  
2.5.1.8 Gelatin medium  
This medium was supplied by Oxoid (Ltd.). It consists of gelatin, 
 distilled water and nutrient agar. An amount of 4 grams of gelatin were 
suspended in 50ml distilled water and added to the melted 1000 ml nutrient 
agar. The complete medium was sterilized by autoclaving at 115ºC for ten 
minutes, and then distributed into sterile bottles . 
2.5.2 Semi-solid media  
2.5.2.1 Hugh and Leifson's (O-F) medium  
  This medium was prepared as described by Hugh and Leifson (1953). 
It consists of potassium hydrogen phosphate, sodium chloride, peptone and 
agar. The solid powders were dissolved by heating in one litre of distilled 
water. The pH was adjusted to7.1, then filtered and aqueous solution at 
0.2% concentration of bromothymol blue indicator was added, then 
sterilized at 115ºC for 20min. A sterile solution of the appropriate 
carbohydrate was added to give a final concentration of 1%. The complete 
medium was distributed into 10ml volumes into sterile test tubes.  
2.5.2.2 Motility medium  
It consists of nutrient broth, distilled water and agar (0.4%). The solid 
powder was suspended in  one litre of distilled water, steamed to dissolve, 
distributed in 5-6ml amounts in test tubes containing Craigie tubes and 
autoclaved at 121ºC for 10 minutes. Then the medium was allowed to cool 
 to become semi solid before using . 
2.5.3 Liquid media  
2.5.3.1 Nutrient broth  
This medium was supplied by Oxoid (Ltd.). It consists of peptone, 
yeast extract and sodium chloride. It was prepared according to Barrow and 
Feltham (1993) by dissolving 13 grams of the medium in one litre of 
distilled water. The pH was adjusted to 7.4 and the medium was distributed 
into screw capped bottles 5 ml each and sterilized by autoclaving at 121ºC 
for 15 minutes . 
2.5.3.2 Peptone water  
It was prepared as described by Barrow and Feltham (1993). Ten 
grams of peptone powder (Oxoid) Ltd. and 5 grams of sodium chloride 
were dissolved in one litre of distilled water. The pH of the medium was 
adjusted to 7.2-7.4, and distributed into sterile screw capped bottles and 
sterilized by autoclaving at 121˚C for 15 minutes. 
2.5.3.3 Peptone water sugar  
This medium was prepared according to Barrow and Feltham (1993). 
Nine hundred ml of peptone water were prepared and the pH was adjusted 
to 7.1-7.3. Ten ml of Andrade's indicator were added. 
  Sugar solution was prepared by dissolving 10 grams of the 
appropriate sugar in 90 ml of peptone water. This sugar solution was added 
to the peptone water, distributed in 5ml volume into sterile test tubes with 
inverted Durham's tubes and sterilized by autoclaving at 115ºC for 10 
minutes . 
 The carbohydrates tested were glucose, mannitol, mannose, xylose, 
raffinose, maltose, sucrose, lactose, arabinose, fructose, trehalose and 
salicin.  
2.5.3.4 Nitrate broth  
This medium contains one gram of potassium nitrate. It was prepared 
according to Barrow and Feltham (1993) by dissolving the nitrate in one 
litre of nutrient broth, distributed in 5ml amounts into test tubes and 
sterilized by autoclaving at 115ºC for 20 minutes. 
2.5.3.5 Glucose-phosphate medium (MR-VP test medium)  
 This medium was prepared according to Barrow and Feltham (1993). 
Five gram of peptone and 5g of phosphate buffer (K2HPO4), were added to 
one litre of distilled water, dissolved by steaming, filtered and pH was 
adjusted to 7.5. Then 5g of glucose were added, mixed well, distributed into 
clean test tubes and sterilized by autoclaving at 115˚C for 15 min. 
 2.6 Sample collection 
The samples were collected from human, cows, goats, poultry and 
horses. Human samples were collected from different hospital in Khartoum 
State. All human and equine samples were collected by swabs, which were 
then labeled and carried on ice to the laboratory. Poultry samples were 
biopsy from liver and intestine. Cow and goat's samples were milk. 
The swab was streaked directly on blood agar and MacConkey agar. 
Milk sample and tissues also were cultured on blood agar and MacConkey 
agar.  
2.7 Cultural method 
2.7.1 Incubation of cultures  
All inoculated solid media were incubated aerobically at 37ºC for 24- 
48 hours.  
 Liquid media were incubated aerobically at 37˚C for 24-48 hours. 
Media inoculated for citrate utilization; urease presence and aesculin 
liquefaction were incubated at 37˚C for up to 7 days.  
2.7.2 Examination of cultures  
Visual examinations of all cultures on solid media were performed 
for detection of growth, colonial morphology and any change in the 
 medium. The liquid media were similarly examined for turbidity, colour 
changes and formation of sediment.  
2.7.3 Pure culture  
  Well-isolated colonies were sub cultured several times on either 
blood agar or nutrient agar medium using wire loop to obtain pure culture, 
the purity of culture was checked by staining with Gram-stain then stored at 
4˚C.  
2.8 Identification of isolated bacteria 
2.8.1 Primary identification 
2.8.1.1 Preparation of smears  
Small inoculum's of bacterium colony was emulsified in a drop of 
sterile normal saline and spread on a clean slide. Smears from liquid media 
were prepared by spreading a loopful on slide. Smears were allowed to dry 
in air and then fixed by gentle heating.  
2.8.1.2 Gram's staining method 
 This was done as described by Barrow and Feltham (1993).  After 
Gram's staining of smears, the stained smears were examined 
microscopically to see the shape, arrangement, and Gram's reaction of the 
bacteria. 
 2.8.1.3 Catalase test  
 The test was carried out as described by Barrow and Feltham (1993). 
A drop of 3% aqueous solution of hydrogen peroxide was placed on a clean 
slide. Small amount of the tested organism colony was added to the drop 
and mixed by a wood stick, production of air bubble indicated positive 
result.  
2.8.1.4 Oxidase test 
   The tested organism was grown on nutrient agar. A piece of filter 
paper soaked in oxidase test reagent and dried at 50ºC, was placed on a 
clean slide. The tested organism was picked with a sterile clean bent glass 
rod and rubbed on the filter paper. A dark purple colour that developed after 
5 -10 seconds indicated positive result.  
2.8.1.5 Motility 
The semi-solid motility medium containing Craigie tube prepared as 
described by Cruickshank et al. (1975) was used to detect motility. A small 
piece of the colony of the tested organism was picked by the end of the 
straight wire and stabbed in the centre of semi-solid agar in the Craigie 
tube, then incubated at 37˚C.  If the growth of the organism out side the 
Craigie tube was detected, the organism was considered motile.  
 2.8.1.6 Oxidation – Fermentation (O-F) test  
  The test was carried out as described by Barrow and Feltham (1993). 
Two tubes of Hugh and Leifson's medium were inoculated with tested 
organism. One was being covered with a layer of sterile soft paraffin to a 
depth of about 1-2cm. They were then incubated at 37˚C and examined 
daily up to seven days. Fermentative organisms changed the colour to 
yellow in both tubes, while oxidative organism changed the colour in tube 
without paraffin layer only.  
2.8.2 Secondary identification of bacteria  
This was done by use of biochemical tests, which were performed as 
described by Barrow and Feltham (1993).  
2.8.2.1 Sugar fermentation test  
 The peptone water sugar medium was inoculated with the tested 
bacterial isolate, which was previously grown on peptone water. The 
inoculated peptone sugar medium was incubated at 37ºC and then examined 
daily for up to 7 days. Acid production was indicated by the development of 
pink colour in the medium, while gas production was indicated by presence 
of empty space in the inverted Durham’s tubes.    
 2.8.2.2 Urease test 
A slope of urea agar medium was inoculated with the tested organism 
and incubated at 37ºC for 24 hours. Change of the colour to pink indicated 
positive reaction.  
2.8.2.3 Coagulase test  
2.8.2.3.1 Slide coagulase test  
This test was carried out to detect bound coagulase (clumping factor). 
Drops of physiological saline were placed on each end of a slide. A small 
proportion of the bacterial culture was emulsified in each of the drops to 
make two thick suspensions. A drop of undiluted rabbit plasma was added 
to one of the suspension and mixed gently. Clumping of the organisms 
within 10 seconds was considered as a positive reaction.  
2.8.2.3.2 Tube coagulase test  
This test was performed to detect free coagulase. Fresh plasma was 
diluted 1: 10 in physiological saline. Half ml of diluted plasma was placed 
in a sterile agglutination test tube and 0.5ml of overnight growth culture of 
the tested organism was added. The inoculated tube was then incubated at 
37ºC. The tube was examined for coagulation after 1, 3 and 24 hours. A 
positive test was indicated by coagulation of the tube contents. Positive and 
 negative controls were included in the test.  
2.8.2.4 Indole production test   
Indole production test was carried out as described by Barrow and 
Feltham (1993). Peptone water was inoculated with the tested organism and 
incubated at 37˚C for 24-48 hours. Then 0.5 ml of Kovac’s reagent was 
added. Production of red colour on the upper layer of the reagent indicated 
positive reaction.  
2.8.2.5 Citrate utilization test 
 Simmon's citrate medium was inoculated with the tested organism 
and incubated at 37ºC for up to 48 hours. Then examined for growth and 
colour change.  Positive test was recognized by turbidity and colour change 
to blue.  
2.8.2.6 Aesculin hydrolysis 
 Aesculin agar was inoculated with the tested organism and was 
incubated at 37ºC for up to 48 hours. Black colour indicated positive 
reaction.  
2.8.2.7 Nitrate reduction  
 The nitrate test was carried out as described by Barrow and Feltham 
(1993). Nitrate broth was inoculated with the tested organism and incubated 
 at 37ºC for up to 5 days. Then 0.5 ml of nitrate reagents A was added 
followed by 0.5 ml of reagent B. Maroon colour indicated a positive 
reaction. To the results that not showed maroon colour within 5 minutes, 
zinc powder was added. Formation of red colour indicated a negative result.  
2.8.2.8 Voges- Proskaüer (VP) test  
Voges-Proskaüer test was performed as described by Barrow and 
Feltham (1993). This test was used to detect production of acetyl methyl-
carbonil. Glucose phosphate medium was inoculated with tested organism 
and incubated at 37˚C for 48 hours. Then 0.6ml of 5% α- naphthol followed 
by a 0.2ml of 40% potassium hydroxide aqueous solution were added to 
one ml of the culture, shake well and examined after 15 minutes and one 
hour. A positive reaction was indicated by appearance bright pink colour.  
2.8.2.9 Methyl red test 
          Glucose phosphate medium was inoculated with the tested organism 
and incubated at 37˚C for 48 hour. Then 5 – 6 drops of methyl red solution 
were added and the tube was shaken. Red colour appearance indicated 
positive reaction.  
2.8.2.10 H2S production by Lead Acetate paper 
 A tube of peptone water was inoculated, and lead acetate paper was 
 inserted between the plug and the tube. The tubes were examined daily for 
seven days for blackening of paper due to H2S production. 
2.8.2.1.1 Novobiocin sensitivity test 
The standard disc diffusion method was used to examine the 
sensitivity of the tested organism to novobiocin, and 5µg novobiocin 
sensitivity disc (Oxoid, Ltd.) was used.  
 A plate of (DST) medium was dried in the incubator at 50ºC for 30 
minutes then a diluted suspension of the tested organism was poured onto 
the surface of the medium in the plate. Excess fluid was drawn off and the 
plate was allowed to dry at room temperature for 30 minutes. The antibiotic 
disc was gently applied on the plate using sterile forceps, and then 
incubated at 37ºC for 24 hours. The result was reported as sensitive if there 
was zone of growth inhibition around the disc or resistant if there was no 
zone of inhibition around the disc. The zone of growth inhibition around the 
disc was measured in millimeters.  
2.9 Sensitivity to antibiotics  
2.9.1 Preparation of antimicrobial discs in the laboratory 
Disc 5-6 mm in diameter was punched out from a sheet of filter paper 
or good quality blotting paper, and then placed in Petri dishes, allowed 
 distance of 2-4mm between each disc and other. The discs were sterilized in 
a hot air oven at 160ºC for one hour or by autoclaving at 115˚C (10 1b / 
inch2) for 15 minutes. The discs were allowed to cool, 20ul (0.02ml) of the 
correct concentration of sterile antimicrobial solution were pipette on each 
disc, then the discs were dried by placing the Petri dish with lids slightly 
raised in a desiccator left in the refrigerator for a few days. The discs 
sometimes were dried at 35-37˚C incubator for 30 minutes. The potency of 
each batch of discs was checked by known control organisms and was 
compared with commercial disc of the same concentration.  
Discs were impregnated with various concentrations of different 
antimicrobial agents, tetracycline hydrochloride (30, 15, 7.5, 3.75, 
1.875µg), cephradine and ampicillin (20, 10, 5, 2.5, 1.25, 0.3125µg), and 
cloxacillin (2, 1, 0.5, 0.25, 0.125µg). The commercial discs used in this 
study were: ampicillin 10µg, colistin sulphate 25µg, cotrimoxazole 25µg, 
gentamicin 10µg, nalidixic acid 30µg, nitrofurantoin 100µg, streptomycin 
10µg, tetracycline 30µg, chloramphenicol 30µg, cloxacillin 5µg, 
erythromycin 15µg, penicillin 1&10i.µ, ciprofloxacin 5µg, vancomycin 
5&30µg, rifampicin 2&5µg, methicillin5&10µg, amikacin 30µg, cephradine 
30µg, cephalothin 30µg, clindamycin 10µg, sulphonamides 300µg.   
 2.9.2 Sensitivity test methods 
2.9.2.1 Method No .1 
The antibiotics sensitivity of some bacterial strains isolated in this 
study were tested by diffusion technique (Curickshank et al., 1975). The 
tested bacterium was grown in peptone water and incubated at 37˚C for two 
hours. The Petri dish containing Diagnostic Sensitivity Test agar medium 
(DST) was dried in oven at 40˚C for 20 minutes, then 1-2 ml of the culture 
was poured on it and the inoculum was distributed and a pipette was used to 
withdraw off the excess fluid and the plate was left to dry at room 
temperature for 15 minutes. Commercial discs obtained form Oxoid (Ltd.) 
and prepared discs were placed on the surface of the inoculated DST agar 
medium. Then incubated aerobically at 37ºC for 16-18 hours. After 
incubation, the plates were examined for growth inhibition around discs and 
the width of zone of growth inhibition was measured in millimeters. 
2.9.2.2 Method No.2 
In this method a sterile wire loop was used to collect material from 
well-isolated colonies of the tested organism. The material was then 
emulsified in 3-4 ml of sterile physiological saline; inoculum of the same 
turbidity was prepared and used throughout the experiment. The turbidity 
standard was prepared as described by Cheesbrough (2000). 
 A sterile swab was used to inoculate a plate of DST agar medium. 
The surface of the agar was allowed to dry at room temperature for 3-5 
minutes. Dispenser or sterile forceps was used to place the antimicrobial 
discs on the surface of the inoculated plates which were allowed to stay at 
room temperature for 30 minutes after application of the discs, inverted and 
then incubated aerobically at 37ºC for 16-18 hours. After incubation, the 
plates were examined for growth inhibition around disc and the width of 
zone of growth inhibition was measured in millimeters. 
2.9.3 Preparation of antimicrobial combination discs  
The mixed antimicrobial solutions were prepared by dissolving 
certain weights of antimicrobial powders in sterile distilled water, mixed 
well until it was completely dissolved.  Mixed antimicrobial solutions 
contained two bactericidal and bactericidal and bacteristatic were prepared.  
A sterile prepared disc 5-6 mm in diameter were impregnated with 
the prepared antimicrobial combined solutions, allowed to dry at 37ºC for 
30 minutes, then kept in sterile labeled bottles and stored at 4˚C. The 
antimicrobial combination discs were prepared in various concentrations. 
The antimicrobial combinations prepared were tetracycline- cloxacillin and 
ampicillin- cephradine. These combinations were tested on Staphylococcus 
aureus, and Klebsiella spp.  
 CHAPTER THREE 
3.   RESULTS 
 3.1 Survey 
Twenty-six swabs were collected from infected human wound. Forty-
nine swabs were collected from human abscess and eight swabs from 
infected human ear from Khartoum, Bahri, Haj El Safi and Omdurman 
hospital in Khartoum State. Fifteen swabs were collected from infected 
equine uterus. Eight samples were collected from mastitic cow's milk, four 
samples from mastitic goat's milk and five samples were collected from 
infected poultry tissues brought to Faculty of Veterinary Medicine (Table 1)  
3.2 Bacterial isolation 
All samples were cultured onto blood agar and MacConkey agar 
media and incubated aerobically at 37°C.  
 One hundred and seven samples (93%) showed bacterial growth, 
while eight samples (7%) did not demonstrate any growth of bacteria. 
3.3 Characterization and identification of isolates  
The bacterial isolates obtained in this investigation were classified on 
the basis of their cultural characteristics, cell morphology, Gram-stain 
reaction and their biochemical properties as described by Barrow and 
Feltham (1993). 
 The isolates were consisted of 117 Gram-positive isolate (101.7%) 
and 36 Gram- negative isolates (31.3%) as shown in tables 4 and 5.  
3.4 Gram- positive Bacteria  
  Total of 117 (101.7%) organisms were characterized as Gram- 
positive bacteria. They were further characterized as Staphylococcus spp 83 
(72.2%), Streptococcus spp 16 (13.9%), Corynebacterium spp 16 (13.9%) 
and Bacillus spp 2 (1.7%) as shown in table 4.  
3.4.1 Staphylococcus spp  
Staphylococci represented the highest percentage of the total Gram- 
positive bacteria isolated (72.2%). Staphylococci species were identified 
according to the scheme of Staphylococci species identification of El 
Sanousi and Saeed (1995). They were identified as forty-nine coagulase-
 positive staphylococci, this represent (59%) of the total Staphylococci 
species. They were twenty-eight (33.7%) S.aureus, nine (10.8%) S.delphini 
and twelve (14.5%) S.intermedius. Thirty-four isolates were coagulase-
negative staphylococci, this represent (41%) of the total Staphylococci 
species. They were thirteen (15.7%) S.caseolyticus, eight (9.6%) S.cohni, 
four (4.8%) S.sciuri and nine (10.8%) S.epidermedis (Fig.1). 
3.4.2 Streptococcus spp 
The Streptococcus spp isolated in this study were identified 
according to their morphology and Gram-stain reaction. They were Gram-
positive cocci, non-motile, non-sporing and arranged in short or long 
chains. They were also identified on the basis of their biochemical 
properties. They were 13.7% of the total Gram-positive bacterial isolation 
(Table 4).  
3.4.3 Corynebacterium spp 
Sixteen isolates were identified as Corynebacterium spp, and these 
represent (13.7%) of the total Gram-positive isolates (Table 4).  
3.4.4 Bacillus spp  
Two isolates were identified as Bacillus spp., and these represent 
(1.7%) of the total Gram-positive isolates (Table 4).  
3.5 Gram-negative Bacteria  
Thirty-six isolates (31.3%) of Gram-negative bacteria were isolated 
in this study. They consist of Escherichia coli 16 (13.9%), Klebsiella spp 11 
(9.6%) and Pseudomonas spp 9 (7.8%) as shown in table 5.  
3.5.1 Escherichia coli  
Sixteen isolates were identified as Escherichia coli, and these were 
the highest percentage (44.4%) of the total Gram-negative isolates (Table 
5). 
3.5.2 Klebsiella spp  
Eleven isolates were identified as Klebsiella spp., and these represent 
30.6% of the total Gram-negative bacteria isolated (Table 5).  
3.5.3 Pseudomonas spp  
 Nine isolates were identified as Pseudomonas spp., and these 
represent 25% of total Gram-negative bacteria isolated (Table 5).  
3.6 Antibiotics sensitivity test 
Ninety- eight bacterial isolates were examined for their sensitivity to 
21 different antimicrobial agents in this study. 
3.6.1 Sensitivity of Staphylococcus spp to antibiotics 
The staphylococcus strains isolated in this study were examined for 
their sensitivity to various antimicrobial agents, they showed very high 
resistance to penicillin (97.9%) and only one isolate was found sensitive to 
penicillin (2.1%). Also the staphylococcal strains isolated in this study 
showed very high resistance to ampicillin (92.9%) and few isolates (7.1%) 
showed intermediate sensitivity and no isolate revealed sensitivity to 
ampicillin. While the sensitivity of the staphylococcal isolates of this study 
to other antimicrobial agents varied between 10.3 % for nalidixic acid and 
83.3 % for vancomycin (Table 8). 
3.6.2 Sensitivity of Streptococcus spp to antibiotics 
The streptococcus strains isolated in this study were examined for 
their sensitivity to various antimicrobial agents; they showed very high 
resistance to nalidixic acid, colistin sulphate, cotrimoxazole, methicillin and 
clindamycin (100%). Also the streptococcal strains isolated in this study 
showed high resistant to penicillin (85.7%), and few isolates (14.3%) 
showed intermediate sensitivity, and no isolate revealed sensitivity to 
penicillin. Also they showed high resistance to ampicillin (80 %) and few 
isolates (20%) showed intermediate sensitivity and no isolate revealed 
sensitivity to ampicillin. While the sensitivity of streptococcal isolates of 
this study to other antimicrobial agents varied between 16.7% for 
cephradine and 83.3% for amikacin (Table 9). 
3.6.3. Sensitivity of Corynebacterium spp to antibiotics   
The Corynebacterium strains isolated in this study were examined for 
their sensitivity to various antimicrobial agents; they showed very high 
resistance to nalidixic acid, methicillin and penicillin (100%). Also the 
Corynebacterium spp isolated in this study showed high resistance to 
 cloxacillin (77.8%) and few isolates (22.2%) showed intermediate 
sensitivity and no isolate revealed sensitivity to cloxacillin. While the 
sensitivity of corynebacterium isolates of this study to others antimicrobial 
agents varied between 11.1% for erythromycin and 80% for nitrofurantoin 
(Table 10). 
3.6.4 Sensitivity of Enterobacteriaceae spp to antibiotics 
The enterobacteriaceae strains isolated in this study were examined 
for their sensitivity to various antimicrobial agents; they showed very high 
resistance to penicillin, cloxacillin, methicillin and vancomycin (100%). 
Also the enterobacteriaceae strains isolated in this study showed high 
resistance to ampicillin (88.9%), and few isolates (11.1%) were sensitive to 
ampicillin. While the sensitivity of enterobacteriaceae isolates of this study 
to others antimicrobial agents varied between 11.1% for ampicillin and 87.5 
% for ciprofloxacin. 
3.6.5 Sensitivity of Pseudomonas spp to antibiotics 
  The pseudomonas strains isolated in this study showed very high 
resistance to penicillin, cloxacillin, methicillin, clindamycin, 
sulphonamides, vancomycin and erythromycin (100%). Also the 
pseudomonas strains isolated in this study showed resistance to 
 cotrimoxazole (60%) and ciprofloxacin (66.7%). While the sensitivity of 
pseudomonas isolates of this study to others antimicrobial agents varied 
between 28.6 % for colistin sulphate and nalidixic acid, and 62.5 % for 
gentamicin (Table 13). 
 
Table 1: Isolation of bacteria from samples collected from human and 
animal sources  
No. of isolation 
negative samples 
(percent)   
No. of isolation 
positive samples 
(Percent) 
No. of samples 
collected  
Source of  
sample  
5 
19.2%  
21 
80.8% 
26  Infected human wound
3 
6.1%  
46 
93.9% 
49 Human abscess
0 
0%  
8 
100% 
8 Infected human ear
0 
0%   
15 
100% 
15 Infected equine uterus
0 
0%   
8 
100% 
8 Mastitic cow's milk 
0 
0%   
4 
100% 
4 Mastitic goat's milk 
0 
0%   
5 
100%  
5 Infected poultry tissues 
(intestine, liver)
 8 
7%   
107 
93%  
115 Total 
Table 2: Gram – positive bacterial species isolated from samples 
collected from human and animal sources 
Source of 
sample 
No. of sample 
examined 
Species of bacteria 
isolated 
No. of 
isolates
Isolation 
rate (%) 
Infected human 
wound 
26 
Staphylococcus spp. 
Streptococcus spp. 
Corynebacterium  spp. 
20 
5 
4 
76.9% 
19.2% 
15.4% 
Total   29 111.5% 
Human abscess 49 
Staphylococcus spp. 
Streptococcus spp. 
Corynebacterium  spp. 
Bacillus   spp. 
40 
4 
4 
2 
81.6% 
8.2% 
8.2% 
4% 
Total   50 102% 
Infected human 
ear 
8 
Staphylococcus spp. 
Streptococcus spp. 
Corynebacterium  spp. 
4 
1 
2 
50% 
12.5% 
25% 
Total   7 87.5% 
Infected equine 
uterus 
15 
Staphylococcus spp. 
Streptococcus spp. 
Corynebacterium  spp. 
9 
3 
6 
60% 
20% 
40% 
Total   18 120% 
Mastitic cow's 
Milk 
8 
Staphylococcus spp. 
Streptococcus  spp. 
4 
2 
50% 
25% 
Total   6 75% 
Mastitic goat's 
milk 
4 Staphylococcus spp. 2 50% 
Total   2 50% 
Infected poultry 
tissues 
(Intestine, liver) 
5 
Staphylococcus spp. 
Streptococcus  spp. 
4  
1 
80% 
20% 
Total   5 100% 
   
 Table 3: Gram – negative bacterial species isolated from samples   
collected from human and animal sources 
Isolation 
rate (%) 
No of 
isolates 
Species of bacteria 
isolated 
No. of 
sample 
examined 
Source of sample 
3.8% 
3.8%  
1 
1 
E .coli 
Klebsiella  spp. 
26 
Infected human 
wound  
7.6% 2   Total 
8.2% 
6.1% 
6.2% 
4 
3 
3 
E .coli 
Klebsiella spp. 
Pseudomonas  spp. 
49 
Human abscess 
  
 
20.4% 10   Total 
50% 
25% 
4 
2 
E .coli 
Klebsiella spp.  
8 Infected human ear 
75% 6   Total 
13.3.% 
6.7% 
40% 
2 
1 
6 
E .coli 
Klebsiella spp. 
Pseudomonas  spp. 
15 
Infected equine 
uterus 
 
60% 9   Total 
37.5% 
25%  
3 
2 
E .coli 
Klebsiella spp.  
8 Mastitic cow's milk 
62.5% 5    Total 
25% 
25% 
1 
1 
E .coli 
Klebsiella spp.  
4 Mastitic goat's milk 
50% 2   Total 
20% 
20%  
1  
1  
E .coli 
Klebsiella spp. 
5  
Infected poultry 
tissues  
(Intestine, liver) 
 40% 2   Total 
 Table 4: Isolation rate of Gram-positive bacteria isolated from human and 
animal sources  
Isolation 
rate (%) 
No of 
isolates 
Species of bacteria Isolated 
No. of sample 
examined 
Source of sample 
72.2%
13.9%
13.9%
1.7%
83
16
16
2
Staphylococcus spp.
Streptococcus spp.
Corynebacterium spp.
Bacillus spp.
115 Infected human wound , human 
abscess, infected human ear, 
infected equine uterus, mastitic 
cow's milk, mastitic goat's milk, 
infected poultry tissues (intestine, 
liver)
101.7%117  Total
 
 
Table 5: Isolation rate of Gram-negative bacteria isolated from human and animal 
sources  
Isolation 
rate (%) 
No of 
isolates
Species of bacteria 
Isolated 
No. of 
sample 
examined 
Source of sample 
13.9%
9.6%
7.8%
16
11
9
 
E. coli.
Klebsiella spp. 
Pseudomonas  spp.
115Infected human wound , 
human abscess, infected 
human ear, infected 
equine uterus, mastitic 
cow's milk, mastitic 
goat's milk, infected 
poultry tissues 
(intestine, liver)
 31.3%36  Total
  
Table 6: Biochemical properties of Gram-positive bacteria isolated from infected 
human wound, human abscess, infected human ear, infected equine uterus, 
mastitic cows and goat's milk and infected poultry tissues in Khartoum State 
Test 
Streptococcus 
spp 
Corynebacterium 
spp 
Bacillus 
spp 
Growth under anaerobic 
conditions 
+ - - 
Catalase - + + 
Oxidase - - - 
VP - - + 
Nitrate reduction - - + 
Carbohydrates fermentation F F Alk 
Haemolysis β/α - β 
Motility - - + 
Growth at 37˚ C + + + 
H2S production - - - 
 
Key:  
(+): positive    (-): negative   F: fermentative    
Alk: Alkaline              β: beta    α: alpha  
 
 Table 7: Biochemical properties of Gram-negative bacteria isolated 
from infected human wound, human abscess, infected human ear, 
infected equine uterus, mastitic cows and goat's milk and infected 
poultry tissues        
Test Escherichia coli Klebsiella spp 
Pseudomonas 
spp 
Shape R R R 
Motility + - + 
Catalase + + + 
Oxidase - - + 
Carbohydrates fermentation 
(O/F) 
F F O 
Pigmentation - - + 
Nitrate reduction + + + 
Citrate utilization - + + 
Urease - + - 
Gelatin liquefaction - - - 
Indole production + Variable - 
Haemolysis - - + 
Growth on MacConkey agar + + + 
MR + - - 
VP - + + 
 (R): Rod shape, (+): Positive, (-): Negative, (F): Fermentative, (O): Oxidative
 Table 8:  Antibiotics sensitivity of Staphylococcus strains isolated from human and animal sources 
No. of isolate sensitive to 
Source of isolation AMP 
10 
COL 
25 
COT 
25 
GEN 
10 
NA 
30 
NIT 
100 
STR 
10 
TET 
30 
CHL 
30 
CXC 
5 
ERY 
15 
PEN 
10 
CIP 
5 
VA 
30 
RD 
5 
MET 
5 
AK 
30 
CE 
30 
KF 
30 
DA 
10 
S 
300 
No. of  isolate 
examined 
14 8 6 14 10 10 13 14 13 13 13 14 5 5 4 5 5 5 5 5 5 
No. of isolate 
sensitive 
0 5 0 12 3 4 2 5 8 7 5 0 2 5 4 5 5 3 5 5 5 
Infected 
human 
wound 
Sensitivity % 0 62.5 0 85.7 30 40 15.4 35.7 61.5 53.8 38.5 0 40 100 100 100 100 60 100 100 100 
No. of  isolate 
examined 
30 11 - 30 8 16 30 26 23 30 30 30 15 16 15 16 15 13 16 15 9 
No. of isolate 
sensitive 
0 4 - 21 0 14 2 10 14 17 11 0 5 14 12 9 6 5 9 7 5 
Human 
abscess 
Sensitivity % 0 36.4 - 70 0 87.5 6.7 38.5 60.9 56.7 36.7 0 33.3 87.5 80 56.3 40 38.5 56.3 46.7 55.6 
No. of  isolate 
examined 
2 2 - 3 2 3 3 3 2 3 3 3 3 3 3 3 2 3 3 3 2 
No. of isolate 
sensitive 
0 2 - 3 0 2 1 0 1 1 0 1 2 1 1 2 1 2 2 1 1 
Mastitic 
cow and 
goat's 
(milk) 
Sensitivity % 0 100 - 100 0 66.7 33.3 0 50 33.3 0 33.3 66.7 33.3 33.3 66.7 50 66.7 66.7 33.3 50 
No. of  isolate 
examined 
9 9 9 9 9 9 9 9 - - - - - - - - - - - - - 
No. of isolate 
sensitive 
0 1 0 7 0 6 7 5 - - - - - - - - - - - - - 
Infected 
equine 
uterus 
Sensitivity % 0 11.1 0 77.8 0 66.7 77.8 55.6 - - - - - - - - - - - - - 
 
AMP: Ampicillin 10µg, COL: Colistin 25µg, COT: Cotrimoxazole 25µg, GEN: Gentamicin 10µg, NA: Nalidixic acid 30µg, NIT.: Nitrofurantoin 100µg, STR: 
Streptomycin 10µg, TET: Tetracycline 30µg, CHL: Chloramphenicol 30µg, CXC: Cloxacillin 5µg, ERY: Erythromycin 15µg,   PEN: Penicillin 10µg, CIP: 
Ciprofloxacin 5µg, VA: Vancomycin 30µg, RD: Rifampicin 5µg, MET: Methicillin 5µg, AK: Amikacin 30µg, Cephradine 30µg, KF: Cephalothin 30µg, DA: 
Clindamycin 30µg, S: Sulphonamides 300µg,  (-): not examined. 
  
Table 9:  Antibiotics sensitivity of Streptococcus strains isolated from human and animal sources 
No. of isolate sensitive to 
       Source of isolation AMP 
10 
COL 
25 
COT 
25 
GEN 
10 
NA 
30 
NIT 
100 
STR 
10 
TET 
30 
CHL 
30 
CXC 
5 
ERY 
15 
PEN 
10 
No. of isolate 
examined 4 4 4 4 3 - 4 4 4 4 4 4 
No. of isolate 
sensitive 0 0 0 2 0 - 2 0 2 1 1 0 
Infected human 
wound  
Sensitivity % 0 0 0 50 0 - 50 0 50 25 25 0 
No. of isolate 
examined 2 2 2 2 2 2 2 1 - 2 1 2 
No. of isolate 
sensitive 0 0 0 2 0 2 0 1 - 1 0 0 
Human abscess  
Sensitivity % 0 0 0 100 0 100 0 100 - 50 0 0 
No. of isolate 
examined 1 1 1 1 1 - 1 1 1 1 1 1 
No. of isolate 
sensitive 0 0 0 1 0 - 1 0 1 1 1 0 
Infected human 
ear  
Sensitivity % 0 0 0 100 0 - 100 0 100 100 100 0 
No. of isolate 
examined 3 3 3 3 3 3 3 3 1 - - - 
No. of isolate 
sensitive 0 0 0 1 0 1 0 1 0 - - - 
Infected equine 
uterus  
Sensitivity % 0 0 0 33.3 0 33.3 0 33.3 0 - - - 
   
AMP: Ampicillin 10µg, COL: Colistin 25µg, COT: Cotrimoxazole 25µg, GEN: Gentamicin 10µg, NA: Nalidixic acid 30µg, NIT: Nitrofurantoin 100µg, 
STR: Streptomycin 10µg, TET: Tetracycline 30µg, CHL: Chloramphenicol 30µg, CXC: Cloxacillin 5µg, ERY: Erythromycin 15µg,   PEN: Penicillin 
10µg, (-): not examined.
  
 
Table 10:  Antibiotics sensitivity of Corynebacterium strains isolated from human and animal sources 
No. of isolate sensitive to 
Source of isolation AMP 
10µg 
COL 
25 µg  
COT 
25 µg 
GEN 
10 µg 
NA 
30 µg 
NIT  
100µg 
STR 
10 µg 
TET 
30 µg 
CHL 
30 µg 
CXC 
5 µg 
ERY 
15 µg 
PEN 
10 i.µ 
No. of isolate 
examined 4 - - 4 - - 4 4 4 4 4 4 
No. of isolate 
sensitive 0 - - 3 - - 1 1 0 0 0 0 
Infected human 
wound 
Sensitivity % 0 - - 75 - - 25 25 0 0 0 0 
No. of isolate 
examined 4 - - 4 - - 4 4 4 4 4 4 
No. of isolate 
sensitive 0 - - 1 - - 2 1 2 1 1 0 
Human abscess 
Sensitivity % 0 - - 25 - - 50 25 50 25 25 0 
No. of isolate 
examined 1 - - 1 - - 1 1 1 1 1 1 
No. of isolate 
sensitive 1 - - 1 - - 1 0 1 1 0 0 
Infected human 
ear 
Sensitivity % 100 - - 100 - - 100 0 100 100 0 0 
No. of isolate 
examined 5 5 5 5 5 5 5 5 - - - - 
No. of isolate 
sensitive 0 1 0 4 0 4 3 4 - - - - 
Infected equine 
uterus 
Sensitivity % 0 20 0 80 0 80 60 80 - - - - 
 
AMP: Ampicillin 10µg, COL: Colistin 25µg, COT: Cotrimoxazole 25µg, GEN: Gentamicin 10µg, NA: Nalidixic acid 30µg, NIT: Nitrofurantoin 100µg, 
STR: Streptomycin 10µg, TET: Tetracycline 30µg, CHL: Chloramphenicol 30µg, CXC: Cloxacillin 5µg, ERY: Erythromycin 15µg,   PEN: Penicillin 
10µg, (-): not examined. 
 Table 11:  Antibiotics sensitivity of E. coli strains isolated from human and animal sources 
No. of isolate sensitive to 
Source of isolation AMP 
10 
COL  
25 
COT 
25 
GEN 
10 
NA 
30 
NIT 
100 
STR 
10 
TET 
30 
CHL 
30 
CXC 
5 
ERY 
15 
PEN 
10 
CIP 
5 
VA 
30 
RD 
5 
MET 
5 
AK 
30 
CE 
30 
KF 
30 
DA 
10 
S 
300 
No. of 
isolate 
examined 
2 2 - 2 2 2 2 2 1 2 2 2 2 2 2 2 2 2 2 2 2 
No. of 
isolate 
sensitive 
0 1 - 1 1 1 0 0 1 0 0 0 1 0 0 0 1 0 0 0 1 
Human 
abscess  
Sensitivity 
% 
0 50 - 50 50 50 0 0 100 0 0 0 50 0 0 0 50 0 0 0 50 
No. of 
isolate 
examined 
2 2 2 2 2 2 2 2 - - - 2 - 2 1 2 - - - 2 2 
No. of 
isolate 
sensitive 
0 0 0 1 0 2 1 1 - - - 0 - 0 0 0 - - - 0 0 
Infected 
equine 
uterus  
Sensitivity 
% 
0 0 0 50 0 100 50 50 - - - 0 - 0 0 0 - - - 0 0 
No. of 
isolate 
examined 
1 1 - 1 1 1 1 1 - 1 1 1 1 1 1 1 1 1 1 1 1 
No. of 
isolate 
sensitive 
0 1 - 1 1 1 1 1 - 0 0 0 0 1 0 0 0 0 0 0 0 
Mastitic 
cow’s 
(milk)  
Sensitivity 
% 
0 100 - 100 100 100 100 100 - 0 0 0 0 100 0 0 0 0 0 0 0 
 
AMP: Ampicillin 10µg, COL: Colistin 25µg, COT: Cotrimoxazole 25µg, GEN: Gentamicin 10µg, NA: Nalidixic acid 30µg, NIT: Nitrofurantoin 100µg, 
STR: Streptomycin 10µg, TET: Tetracycline 30µg, CHL: Chloramphenicol 30µg, CXC: Cloxacillin 5µg, ERY: Erythromycin 15µg,   PEN: Penicillin 
10µg, CIP: Ciprofloxacin 5µg, VA: Vancomycin 30µg, RD: Rifampicin 5µg, MET: Methicillin 5µg, AK: Amikacin 30µg,       CE. Cephradine 30µg, KF: 
Cephalothin 30µg, DA: Clindamycin 30µg, S: Sulphonamides 300µg, (-): not examined. 
 
 
  
Table 12:  Antibiotics sensitivity of Klebsiella strain isolated from human and animal sources 
No. of isolate sensitive to 
Source of isolation AMP 
10 
COL  
25 
COT  
25 
GEN 
10 
NA 
30 
NIT 
100 
STR 
10 
TET 
30 
CHL 
30 
CXC 
5 
ERY 
15 
PEN 
10 
CIP 
5 
VA 
30 
RD 
5 
MET 
5 
AK 
30 
CE 
30 
KF 
30 
DA 
10 
S 
300 
No. of 
isolate 
examined 
1 - - 1 - - 1 1 1 1 1 1 1 1 - 1 - - - 1 - 
No. of 
isolate 
sensitive 
1 - - 1 - - 0 1 0 0 0 0 1 0 - 0 - - - 0 - 
Infected 
human 
wound  
Sensitivity 
% 
100 - - 100 - - 0 100 0 0 0 0 100 0 - 0 - - - 0 - 
No. of 
isolate 
examined 
1 1 - - - 1 1 1 - 1 - 1 1 1 - 1 1 1 1 1 1 
No. of 
isolate 
sensitive 
0 1 - - - 0 0 0 - 0 - 0 1 0 - 0 1 0 0 0 1 
Infected 
Human 
ear 
Sensitivity 
% 
0 100 - - - 0 0 0 - 0 - 0 100 0 - 0 100 0 0 0 100 
No. of 
isolate 
examined 
2 1 - 2 1 2 2 2 1 2 2 2 2 2 2 2 1 2 2 2 1 
No. of 
isolate 
sensitive 
0 1 - 2 1 1 1 1 1 0 0 0 2 0 0 0 1 1 2 0 1 
Mastitic 
cow’s 
milk  
Sensitivity 
% 
0 100 - 100 100 50 50 50 100 0 0 0 100 0 0 0 100 50 100 0 100 
 
AMP: Ampicillin 10µg, COL: Colistin 25µg, COT: Cotrimoxazole 25µg, GEN: Gentamicin 10µg, NA: Nalidixic acid 30µg, NIT.: Nitrofurantoin 100µg, 
STR: Streptomycin 10µg, TET: Tetracycline 30µg, CHL: Chloramphenicol 30µg, CXC: Cloxacillin 5µg, ERY: Erythromycin 15µg,   PEN: Penicillin 
10µg, CIP: Ciprofloxacin 5µg, VA: Vancomycin 30µg, RD: Rifampicin 5µg, MET: Methicillin 5µg, AK: Amikacin 30µg, Cephradine 30µg, KF: 
Cephalothin 30µg, DA: Clindamycin 30µg, S: Sulphonamides 300µg,  (-): not examined. 
 
  
 
 
Table: 13: Antibiotics sensitivity of Pseudomonas strains isolated from human and animal sources  
No. of isolate sensitive to 
Source of isolation AMP 
10 
COL  
25 
COT 
25 
GEN 
10 
NA 
30 
NIT 
100 
STR 
10 
TET 
30 
No. of 
isolate 
examined 
3 3 3 3 3 3 3 3 
No. of 
isolate 
sensitive 
1 1 0 2 0 0 1 0 
Infected 
Human 
wound  
Sensitivity 
% 
33.3 33.3 0 66.7 0 0 33.3 0 
No. of 
isolate 
examined 
5 5 5 5 5 5 5 5 
No. of 
isolate 
sensitive 
3 4 2 3 2 3 3 4 
Infected 
equine 
uterus  
Sensitivity 
% 
60 80 40 60 40 60 60 80 
 
 
AMP: Ampicillin 10µg, COL: Colistin 25µg, COT: Cotrimoxazole 25µg, GEN: Gentamicin 10µg, NA: Nalidixic acid 30µg, NIT: Nitrofurantoin 100µg, 
STR: Streptomycin 10µg, TET: Tetracycline 30µg, (-): not examined. 
  
 
Table 14:  Antibiotics resistance of Gram-positive bacteria isolated from human and animal sources 
No. of isolate resistant 
Source of isolation AMP 
10 
COL  
10 
COT 
25  
GEN 
10  
NA 
30 
NIT 
100 
STR 
10 
TET 
30 
CHL 
30 
CXC 
5 
ERY 
15 
PEN 
10 
CIP 
5 
VA 
30 
RD 
5 
MET 
5 
AK 
30 
CE 
30 
KF 
30 
DA 
10 
S 
300 
No. of isolate 
examined 
56 30 16 57 29 38 56 52 39 47 47 48 23 24 22 24 22 21 24 23 16 
No. of isolate 
resistant  
52 11 9 9 20 11 31 27 4 16 12 47 8 3 4 7 5 9 7 6 4 
Staphylococcus 
spp. 
Resistance % 92.9 36.7 56.3 15.8 69 29 55.4 52 10.3 34 25.5 97.9 34.8 12.5 18.2 29.2 22.7 42.9 29.2 26.1 25 
No. of isolate 
examined 
10 10 10 10 9 5 10 9 6 7 6 7 - - - 9 6 6 7 7 5 
No. of isolate 
resistant  
8 10 10 3 9 2 6 6 1 4 0 6 - - - 9 1 3 3 7 1 
Streptococcus 
spp.  
Resistance % 80 100 100 30 100 40 60 66.7 16.7 57.1 0 85.7 - - - 100 16.7 50 42.8 100 20 
No. of isolate 
examined 
14 5 5 14 5 5 14 14 9 9 9 9 - - - - - - - - - 
No. of isolate 
resistant  
9 2 3 3 5 1 6 7 6 7 4 9 - - - - - - - - - 
Coryne-
bacterium spp.  
Resistance % 64.3 40 60 21.4 100 20 42.9 50 66.7 77.8 44.4 100 - - - - - - - - - 
 
AMP: Ampicillin 10µg, COL: Colistin 25µg, COT: Cotrimoxazole 25µg, GEN: Gentamicin 10µg, NA: Nalidixic acid 30µg, NIT.: Nitrofurantoin 100µg, STR: 
Streptomycin 10µg, TET: Tetracycline 30µg, CHL: Chloramphenicol 30µg, CXC: Cloxacillin 5µg, ERY: Erythromycin 15µg,   PEN: Penicillin 10µg, CIP: 
Ciprofloxacin 5µg, VA: Vancomycin 30µg, RD: Rifampicin 5µg, MET: Methicillin 5µg, AK: Amikacin 30µg, Cephradine 30µg, KF: Cephalothin 30µg, DA: 
Clindamycin 30µg, S: Sulphonamides 300µg,  (-): not examined. 
  
   Table 15:  Antibiotics resistance of Gram-negative bacteria isolated from human and animal sources 
No. of isolate resistant 
Source of isolation AMP 
10 
COL   
10  
COT  
25 
GEN 
10 
NA 
30 
NIT 
100 
STR 
10 
TET 
30 
CHL 
30 
CXC 
5 
ERY 
15 
PEN 
10 
CIP 
5 
VA 
30 
RD 
5 
MET 
5 
AK 
30 
CE 
30 
KF 
30 
DA 
10 
S 
300 
No. of 
isolate 
examined 
5 5 2 5 5 5 5 5 1 3 3 5 3 5 5 5 3 3 3 5 3 
No. of 
isolate 
resistant  
5 1 2 0 1 1 3 3 0 3 2 5 1 5 4 5 0 2 2 5 1 E. coli  
Resistance 
% 
100 20 100 0 20 20 60 60 0 100 66.7 100 33.3 100 80 100 0 66.7 66.7 100 33.3 
No. of 
isolate 
examined 
4 2 - 3 1 3 4 4 2 4 3 4 4 4 3 4 2 3 3 4 2 
No. of 
isolate 
resistant  
3 0 - 0 0 2 2 1 1 4 2 4 0 4 3 4 0 1 1 4 0 
Klebsiella 
spp.  
Resistance% 75 0 - 0 0 66.7 50 25 50 100 66.7 100 0 100 100 100 0 33.3 33.3 100 0 
No. of 
isolate 
examined 
8 7 5 8 7 7 8 8 2 2 6 7 6 8 4 8 2 2 2 8 5 
No. of 
isolate 
resistant  
4 1 3 1 4 3 3 4 1 2 6 7 4 8 4 8 1 1 1 8 5 
Pseudomonas 
spp.  
Resistance 
% 
50 14.3 60 12.5 57.1 42.9 37.5 50 50 100 100 100 66.7 100 100 100 50 50 50 100 100 
 
AMP: Ampicillin 10µg, COL: Colistin 25µg, COT: Cotrimoxazole 25µg, GEN: Gentamicin 10µg, NA: Nalidixic acid 30µg, NIT.: Nitrofurantoin 100µg, 
STR: Streptomycin 10µg, TET: Tetracycline 30µg, CHL: Chloramphenicol 30µg, CXC: Cloxacillin 5µg, ERY: Erythromycin 15µg,   PEN: Penicillin 
10µg, CIP: Ciprofloxacin 5µg, VA: Vancomycin 30µg, RD: Rifampicin 5µg, MET: Methicillin 5µg, AK: Amikacin 30µg, Cephradine 30µg, KF: 
Cephalothin 30µg, DA: Clindamycin 30µg, S: Sulphonamides 300µg,  (-): not examined. 
 Table 16: Sensitivity of Staphylococcus aureus to combinations of two antimicrobial 
agents (ampicillin and cephradine)  
Ampicillin Cephradine 
conc. 
Inhibition 
zone 
conc. 
Inhibition 
zone 
Ampicillin +     Cephradine 
       conc.                 conc.       
   
Inhibition 
zone 
20µg 32mm 20µg 16mm 20µg + 20µg  30mm 
10µg 29mm 10µg 13mm 10µg + 10µg  28mm 
5µg 23mm 5µg 9mm 5µg + 2.5µg  24mm 
1.25µg 0 1.25µg 0 1.25µg + 1.25µg  17mm 
1.3125 µg 0 1.3125 µg 0 0.3125µg + 0.3125 µg  11mm 
 
Table 17: Sensitivity of Klebsiella spp to combinations of two antimicrobial agents (ampicillin and 
cephradine) 
Ampicillin Cephradine 
conc. 
Inhibition 
zone 
conc. 
Inhibition 
zone 
Ampicillin +     Cephradine 
       conc.                 conc.       
   
Inhibition 
zone 
20µg 12mm 20µg 0 20µg + 20µg  10mm 
10µg 9mm 10µg 0 10µg + 10µg  8mm 
5µg 0 5µg 0 5µg + 2.5µg  0 
1.25µg 0 1.25µg 0 1.25µg + 1.25µg  0 
 1.3125 µg 0 1.3125 µg 0 0.3125µg + 0.3125 µg  0 
  
 
 
 
Table 18: Sensitivity of Staphylococcus aureus to combinations of two 
antimicrobial agents (tetracycline and cloxacillin)  
 
 
Tetracycline Cloxacillin 
conc. 
Inhibition 
zone 
conc. 
Inhibition 
zone 
Tetracycline +     Cloxacillin 
       conc.                 conc.       
   
Inhibition 
zone 
30µg 24mm 2µg 0 15 µg + 0.5µg  20mm 
15µg 20mm 1µg 0 15 µg +0.5µg  17mm 
7.5µg 19 mm 0.5µg 0 7.5 µg +0.25 µg  16.5mm 
3.75µg 18 mm 0.25µg 0 3.75 µg + 0.25 µg  16mm 
1.875 µg 17 mm 0.125 µg 0 1.875 µg + 0.125 µg  14.5 mm 
  
 
 
Table 19: Sensitivity of Klebsiella spp to combinations of two 
antimicrobial agents (tetracycline and cloxacillin)  
Tetracycline Cloxacillin 
conc. 
Inhibition 
zone 
conc. 
Inhibition 
zone 
Tetracycline +     Cloxacillin 
       conc.                 conc.       
   
Inhibition 
zone 
30µg 17mm 2µg 0 15 µg + 0.5µg  16mm 
15µg 16mm 1µg 0 15 µg +0.5µg  15mm 
7.5µg 14 mm 0.5µg 0 7.5 µg +0.25 µg  13mm 
3.75µg 12mm 0.25µg 0 3.75 µg  + 0.25 µg  11mm 
1.875 µg 11mm 0.125µg  0 1.875 µg  + 0.125 µg  9 mm 
 S. aureus  33.7%
S. sciuri 4.8%
S. cohnii 9.6%S. delphini 10.8%
S. epidermidis 10.8%
S. intermedius 14.5%
S. caseolyticus 15.7%
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Staphylococci strains isolated from infected human wound, 
human abscesses, infected human ear, infected equine 
uterus, mastitic cow and goat’s milk and infected poultry 
tissues in Khartoum State.  
 
 Fig. 2. Two strains of staphylococcus bacteria isolated 
from human sources on blood agar medium.  
Fig. 3. Antibiotics sensitivity of Staphylococcus aureus 
isolated from infected equine uterus showed 
synergistic effect on DST agar medium.   
 Fig. 4. Staphylococcus aureus isolated from infected 
human wound showed multi-drug resistance to 
(AMP, PEN, NA, NIT, STR and COT) on DST 
agar medium.   
Fig. 5. Corynebacterium spp. isolated from infected human 
wound showed multi-drug resistance to (AMP, GEN, 
CHL, TET, PEN, CXC, STR and ERY) on DST agar 
medium.   
 Fig. 6. Antibiotics sensitivity of E. coli isolated from infected 
human ear to (KF, DA, NIT, CIP, TET, NA, AK and CT 
(which the bacterium showed resistance to it) on blood 
agar medium.    
Fig. 7. Pseudomonas spp. isolated from human abscess showed 
multi-drug resistance to (DA, NIT, TET, PEN, CT, VA, 
ERY, and STR) on DST agar medium.    
  
Fig. 8. Staphylococcus intermedius isolated from infected 
human wound on blood agar medium.  
Fig. 9. Staphylococcus epidermidis isolated from human 
abscess on blood agar medium.   
 Fig. 10. Antibiotics sensitivity of Staphylococcus epidermidis 
isolated from infected equine uterus on DST agar 
medium.
Fig. 11. Antibiotics sensitivity of E. coli isolated from 
mastitic cow’s milk on DST agar medium. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12. Antibiotics sensitivity of Staphylococcus aureus 
isolated from human abscess on DST agar medium.  
Fig. 13. Staphylococcus caseolyticus isolated from infected 
human wound on blood agar medium  
 CHAPTER FOUR 
DISCUSSION 
Swabs were collected from infected human wound, human abscess, 
infected human ear, infected equine uterus, mastitic cows and goat's milk 
and infected poultry tissues (intestine, liver) and they were examined for the 
presence of bacterial infection and the isolated strains were examined for 
their antibiotics sensitivity. One hundred and fifteen swabs were collected, 
cultured and incubated aerobically at 37°C. One hundred and seven (93%) 
samples showed bacterial growth. The results revealed that 80.8% of 
infected human wound, 93.9% of human abscess, 100% of infected human 
ear, 100% of infected equine uterus, 100% of mastitic cows and goat's milk 
and 100% of infected poultry tissues gave bacterial growth when cultured 
onto blood agar and MacConkey agar medium.  
 The most common organism isolated in this study was 
Staphylococcus spp., which accounted for 72.2% of the isolation in this 
study. Staphylococcus spp represented 76.9% of infected human wound, 
81.6% of human abscess, 50% of infected human ear, 60% of infected 
equine uterus, 50% of mastitic cows and goat's milk and 80% of infected 
poultry tissues. This revealed that, the staphylococcal infection is most 
common type of bacterial infection in infected human wound, human 
 abscess, infected human ear, infected equine uterus, mastitic cows and 
goat's milk and infected poultry tissues in Khartoum State. The 
Streptococcus spp (13.9%) are second bacterial infections, while the others 
aerobic bacterial infection such as corynebacteria (13.9%), E. coli (13.9%), 
Klebsiella spp (9.6%) and Pseudomonas spp (7.8%) are less frequent.  
 The results of antibiotics sensitivity testing in this study showed 
response and resistance of the different isolates to different antibiotics were 
varied. It was found that the staphylococcus isolates showed high resistance 
to penicillin (97.9%) and ampicillin (92.9%). This finding agree with 
Forbes et al. (1998) who reported that staphylococci are the Gram–positive 
bacteria that most commonly produced β-lactamase and approximately 90% 
or more of clinical isolates are resistant to penicillin as result of enzyme 
production. These findings also are in agreement with Jawetz et al. (1989) 
who reported that after massive use of penicillin, 65 – 85% of staphylococci 
isolated from hospitals in 1948 were β-lactamase producers and thus 
resistant to penicillin. Some staphylococcus strains found resistant to 
erythromycin. This finding agrees with Davies (1992) who stated that the 
ribosome of staphylococci could become insensitive to erythromycin 
following specific enzymatic modifications of rRNA. Staphylococci strains 
 isolated in this study from mastitic cows and goat's milk showed complete 
resistance (100%) to tetracycline. This result was in agreement with Roberts 
(1990) who reported that, Tet M, a gene that confers tetracycline resistance, 
was particularly common, and was identified in staphylococci. Thomas 
(1993) mentioned that, not antibacterial drug-resistance properties of cells 
can be attributed to genes carried by plasmids. Drug resistance genes may 
also be chromosomally determined.  
Most of streptococci strains isolated in this study showed resistant to 
streptomycin. This finding was in agreement with Jawetz et al. (1989) who 
stated that, streptococci have natural permeability barrier to 
aminoglycosides. Streptococcus isolates were high resistant to ampicillin 
(80%) and penicillin (85.7%).  While corynebacterium, isolates were also 
showed resistant to ampicillin (64.3%) and completely resistant to penicillin 
and nalidixic acid (100%). E.coli isolates were completely resistant to 
ampicillin (100%), cotrimoxazole (100%), cloxacillin (100%), penicillin 
(100%), vancomycin (100%), methicillin (100%), and clindamycin (100%). 
While klebsiella isolates showed high resistance to ampicillin (75%) and 
complete resistance to cloxacillin (100%), penicillin (100%), vancomycin 
(100%), methicillin (100%), rifampicin (100%) and clindamycin (100%). 
 The pseudomonas isolates were completely resistant to cloxacillin (100%), 
erythromycin (100%), penicillin (100%), vancomycin (100%), methicillin 
(100%), rifampicin (100%), sulphonamides (100%) and clindamycin 
(100%) and half of the isolates were resistant to ampicillin (50%). This very 
high resistance showed by various bacterial species isolated from human 
and animal sources to many antibiotics may be due to wide misuse of 
antibiotic in human and Veterinary medicine.    
 However, in this study, the staphylococcus isolates collected from 
infected human wound were found highly sensitive to vancomycin (100%). 
This finding agrees with report of Cheesbrough (2000). In addition, the 
staphylococcus isolates collected from human abscess were found highly 
sensitive to nitrofurantoin and vancomycin (87.5%). This finding was in 
agreement with Masaudi et al. (1990) and Forbes et al. (1998) who reported 
that vancomycin is the only cell wall inhibiting agent for use against Gram-
positive organisms that are resistant to all currently available beta–lactams 
methicillin-resistant staphylococci. Completely sensitive (100%) 
staphylococci strains to clindamycin were isolated from infected human 
wound, and highly sensitive (87.5%) staphylococci strains to vancomycin 
and nitrofurantoin were isolated from human abscess, this probably because 
 these two antibiotics are rarely used for treatment of human wound and 
abscess infection in Khartoum State. Staphylococci strains isolated from 
infected human wound showed complete sensitivity (100%) to rifampicin 
and the staphylococci strains isolated in this study from human abscess 
showed high sensitivity (80%) to rifampicin. This result was similar to that 
reported by Thomas (1993) who stated that, rifampicin derivatives of the 
rifamycin family of antibiotics and was mainly active against Gram-positive 
organism. 
E. coli isolated from infected equine uterus showed no sensitivity 
(0%) to clindamycin and E. coli isolated from human abscess and mastitic 
cow's milk showed no sensitivity (0%) to clindamycin and no sensitivity 
(0%) to erythromycin. Klebsiella strains isolated in this study from infected 
human wound and mastitic cow's milk were not sensitive (0%) to 
erythromycin and clindamycin. Also all pseudomonas strains isolated from 
human and animal sources showed no sensitivity (0%) to erythromycin and 
clindamycin. This primarily because of the uptake difficulties associated 
with Gram-negative outer membrane, the macrolides and clindamycin 
generally are not effective against most genera of Gram-negative bacteria. 
However, they are effective against Gram-positive bacteria (Forbes et al., 
 1998). E.coli isolated from human abscess and infected equine uterus 
showed no sensitivity (0%) to vancomycin. Also Klebsiella strains isolated 
in this study from infected human wound, infected human ear and mastitic 
cow’s milk were not sensitive to vancomycin (0%). This finding is in 
agreement with Forbes et al. (1998) who reported that, vancomycin can not 
penetrate the outer membrane of most Gram-negative bacteria to reach their 
cell wall precursor targets, because of its relatively large size.  
 E.coli isolated from mastitic cow's milk and Klebsiella strains 
isolated from infected human ear and mastitic cow's milk were completely 
sensitive to colistin (100%). The pseudomonas strains isolated from 
infected equine uterus showed high sensitivity (80%) to colistin. While 
streptococci strains isolated from infected human wound, human abscess, 
infected human ear and infected equine uterus showed no sensitivity (0%) 
to colistin. The staphylococci strains isolated from human abscess, infected 
equine uterus showed low sensitivity to colistin. The corynebacteria strains 
isolated from infected equine uterus also showed poor sensitive (20%) to 
colistin. These findings agrees with those reported by Thomas (1993) who 
found that, colistin is more active against Gram-negative, while activity 
against Gram-positive bacteria tends to be poor.  
 In this study streptococci strains and corynebacteria strains isolated 
from infected human ear showed complete sensitivity to gentamicin 
(100%), streptomycin (100%), chloramphenicol (100%) and cloxacillin 
(100%). Streptococci strains isolated from human abscess showed complete 
sensitivity to gentamicin (100%), nitrofurantoin (100%) and tetracycline 
(100%). Staphylococci strains isolated from infected human wound showed 
complete sensitivity to vancomycin (100%), rifampicin (100%), methicillin 
(100%), amikacin (100%), cephalothin (100%), clindamycin (100%) and 
sulphonamides (100%). Staphylococci strains isolated from mastitic cows 
and goat’s milk showed complete sensitivity to colistin sulphate (100%) 
and gentamicin (100%). Corynebacteria strains isolated from infected 
equine uterus were found highly sensitive (80%) to tetracycline, 
nitrofurantoin and gentamicin. Staphylococci strains isolated from infected 
human wound showed high sensitivity (85.7%) to gentamicin. While 
staphylococci strains isolated from infected equine uterus showed high 
sensitivity (77.8%) to streptomycin. E. coli isolated from human abscess 
showed completely sensitive to chloramphenicol (100%), while E.coli 
isolated from mastitic cow’s milk showed complete sensitivity to colistin 
sulphate (100%), gentamicin (100%), nalidixic acid (100%), nitrofurantoin 
 (100%), streptomycin (100%), tetracycline (100%) and vancomycin 
(100%). Klebsiella strains isolated from mastitic cow’s milk and infected 
human ear showed complete sensitivity (100%) to colistin sulphate (100%), 
ciprofloxacin (100%), amikacin (100%) and sulphonamides (100%). This 
because colistin sulphate, ciprofloxacin, amikacin, and sulphonamides are 
used rarely for treatment of mastitis in cows and goats and treatment of 
infected human ear. Pseudomonas strains isolated from infected human 
wound were sensitive (66.7%) to gentamicin and pseudomonas strains 
isolated from infected equine uterus were also sensitive (80%) to 
tetracycline and colistin sulphate.  
The effects of combination of antibiotics were examined in this study 
on Staphylococcus aureus and Klebsiella spp. When sensitivity of 
Staphylococcus aureus to combination of two bactericidal drugs (ampicillin 
and cephradine) was examined, the results in low concentrations equal to 
and less than 5µg revealed an increase in width of inhibition zone. This 
probably synergistic effect and this finding agree with that by Baker and 
Breach (1980) who stated that, when two bactericidal antibiotics were given 
together, the resulting action was synergistic.  
When sensitivity of Staphylococcus aureus and Klebsiella spp to 
combinations of bacteristatic and bactericidal antibiotics (tetracycline and 
 cloxacillin) were examined, the results revealed decrease in width of 
inhibition zone. This probably antagonistic effect and these findings agree 
with those by Baker and Breach (1980) who stated that, when a bacteristatic 
and bactericidal antibiotics were given together, the result was antagonistic. 
When sensitivity of Klebsiella spp to combinations of two bactericidal 
antibiotics (ampicillin and cephradine) was examined, the result not 
produced synergistic effect. This finding was agree with Hugo and Russell 
(1989) who mentioned that, it must also be noted that a combination of two 
β-lactams does not necessarily produce a synergistic effect.   
Bacteria resistant to several antibiotics were first reported in the 
1950s from Japan. They were strains of shigella dysentery causing 
organism, which had been isolated from antibiotic treated patients. It was 
noted that the bacteria showed resistance to several different antibiotics 
(Schlegel, 1995). Many staphylococci isolated in this study showed 
resistance to more than one antimicrobial agent. Staphylococcal multi-
resistance varied from two drugs multi-resistance (ampicillin and penicillin) 
to ten drugs multi-resistance (ampicillin, gentamicin, streptomycin, 
cloxacillin, penicillin, ciprofloxacin, erythromycin, methicillin, amikacin 
and cephalothin). Staphylococci strains showed the highest multi drug 
resistance were isolated from human abscess (up to 10 antibacterial drugs) 
and infected human wound (up to 8 antibacterial drugs), infected equine 
uterus (up to 3 antibacterial drugs) and infected human ear (= 2 antibacterial 
drugs). Many staphylococci strains isolated in this study showed multi-drug 
resistance to many antimicrobial agents and this finding agrees with that 
observed by Cohen (1992) who reported that multiple-drug resistant has 
been demonstrated in Mycobacterium tuberculosis, haemophilus, proteus, 
salmonella, serratia and Staphylococcus aureus. Pratt (1990) mentioned that 
the R plasmids were found in a wide variety of bacteria, but they were 
particularly important in staphylococci and other Gram-positive bacteria, in 
which they were responsible for most or all of the plasmid-mediated drug 
resistance. Streptococci strains isolated in this study showed resistance to 
more than one antimicrobial agent. Streptococci multi-resistance varied 
from five multi-resistance drugs (ampicillin, colistin sulphate, 
cotrimoxazole, nalidixic acid and tetracycline) to ten multi-resistance drugs 
(ampicillin, colistin sulphate, cotrimoxazole, gentamicin, nalidixic acid, 
streptomycin, chloramphenicol, cloxacillin, penicillin and tetracycline). 
Streptococci strains showed the highest multiple-drug resistance isolated 
from infected human wound (up to 10 antimicrobial drugs), infected equine 
 uterus and human abscess (up to 7 antimicrobial drugs) and infected human 
ear (up to 5 antimicrobial drugs). Many streptococci strains isolated in this 
study showed multi-drug resistance to many antimicrobial agents. This 
finding is in agreement with Cohen (1992) who demonstrated multi-drug 
resistance in streptococcus and some others bacteria.  
 Many corynebacterium strains isolated in this study showed 
resistance to more than one antimicrobial agent. Corynebacterium multi-
drug resistance varied from multi-resistance of two antimicrobial agents 
(penicillin and tetracycline) to that of eight antimicrobial agents (ampicillin, 
gentamicin, streptomycin, chloramphenicol, cloxacillin, penicillin, 
tetracycline and erythromycin). Corynebacteria strains showed the highest 
multiple-drugs resistance were isolated from infected human wound (up to 
8 antimicrobial drugs), human abscesses (up to 6 antimicrobial drugs), 
infected equine uterus (up to 4 antimicrobial drugs) and infected human ear 
(= 2 antimicrobial drugs). 
 Also Escherichia coli strains isolated in this study showed resistance 
to more than one antimicrobial agent. E. coli multi-drug resistance varied 
from multi-resistance of six antimicrobial agents (ampicillin, 
cotrimoxazole, penicillin, vancomycin, methicillin and clindamycin) to that 
of eleven antimicrobial agents (ampicillin, streptomycin, cloxacillin, 
penicillin, vancomycin, rifampicin, erythromycin, methicillin, tetracycline, 
cephalothin and clindamycin). E.coli strains showed the highest multiple-
 drugs resistance isolated from human abscess (up to 11 antimicrobial 
drugs), mastitic cow’s milk (up to 9 antimicrobial drugs) and infected 
equine uterus (up to 6 antimicrobial drugs). Many Escherichia coli strains 
isolated in this study showed resistance to many antimicrobial agents. This 
finding agrees with Cohen (1992) who reported multi-resistance in 
Escherichia and some Gram-negative and Gram-positive bacteria. Resistant 
enterobacteriaceae frequently contain multiple plasmids, the larger of which 
can carry genes for resistance to 10 or more antimicrobial agents (Jacoby, 
1991). This may explain the E.coli very high multiple-drug resistance (up to 
11 antimicrobial drugs) observed in this study. All Escherichia coli isolated 
in this study were resistant to one or more of beta–lactam antibiotics. This 
probably due to the fact that Gram-negative bacteria, including 
enterobacteriaceae and others produce dozens of different β-lactamase types 
that mediate resistance to one or more of the beta-lactam antibiotics (Forbes 
et al., 1998). Escherichia coli resistance to clindamycin and erythromycin 
observed in this study might be chromosomally determined. The resistance 
to clindamycin and erythromycin by escherichia is chromosomally 
determined (Hugo and Russell, 1989).  
 The klebsiella isolates of this study revealed resistance to more than 
 one antimicrobial agent. The klebsiella multi-drug resistance varied from 
multi-resistance of seven antimicrobial agents (ampicillin, cloxacillin, 
penicillin, vancomycin, rifampicin, methicillin, and clindamycin) to that of 
eleven antimicrobial agents (ampicillin, nitrofurantoin, streptomycin, 
cloxacillin, penicillin, vancomycin, methicillin, tetracycline cephradine, 
cephalothin and clindamycin). The klebsiella strains revealed the highest 
resistance isolated from infected human ear (up to 11 antimicrobial agents), 
infected human wound (up to 9 antimicrobial drugs) and mastitic cow’s 
milk (up to 7 antimicrobial drugs). Multiple-drug resistance has been 
demonstrated in Klebsiella and other organisms (Cohen, 1992)  
 Many pseudomonas strains isolated in this study revealed resistance 
to more than one antimicrobial agent. Pseudomonas multiple-drug 
resistance varied from multi-resistance of three antimicrobial agents 
(vancomycin, methicillin, and clindamycin) to that of eleven antimicrobial 
drugs (colistin sulphate, nitrofurantoin, cloxacillin, penicillin, vancomycin, 
rifampicin, erythromycin, methicillin, tetracycline, clindamycin and 
streptomycin). The pseudomonas strains revealed the highest resistance 
were isolated from infected human wound (up to 11 antimicrobial drugs), 
infected equine uterus (up to 10 antimicrobial drugs). Cohen (1992) 
 reported that pseudomonas and other bacteria have demonstrated multiple-
drug resistance.  
 Very high multi-resistant strains of staphylococci, streptococci, 
corynebacterium and klebsiella were isolated from infected human wound 
in this study. This may be a result of wide overuse of antimicrobial agents 
for treatment of wound. These findings also indicate a problem of infected 
wound treatment may be encountered in the future as this study showed 
only few antimicrobial drugs are now available for treatment of wound 
infection. Resistance may spread to a wide variety of clinically important 
bacteria, and any single organism can acquire multiple genes and become 
resistant to the full spectrum of available antimicrobial agents (Forbes et al., 
1998). For example, there already exists strains of enterococci and 
Pseudomonas aeuroginosa for which no effective therapy is currently 
available (Forbes et al., 1998).   
The enterobacteriaceae, E.coli and Klebsiella spp showed high multi-
drug resistance were isolated in this study from milk of mastitic cows, thus 
milk might play a role in dissemination of high multi-resistance strains of 
such organisms among human population if milk is not properly collected 
and treated by boiling or pasteurization.  
 When a resistance mechanism arises, either by mutation or gene 
transfer, in a particular bacterial strains or species, there is a propensity for 
this mechanism to then be passed on to other organisms using commonly 
described paths of genetic communication. Therefore, resistance may 
spread to a wide variety of clinically important bacteria, and any single 
organism can acquire multiple genes and become resistant to the full 
spectrum of available antimicrobial agents (Forbes et al., 1998). For 
example, there already exists a strain of enterococci and Pseudomonas 
aeruginosa for which no effective therapy is currently available. 
Alternatively, multiple resistances may be mediated by a gene that encodes 
for a single very potent resistance mechanism. One such example is the 
mecA gene that encodes staphylococcal resistance to methicillin and to all 
other β-lactams currently available for use against these organisms, leaving 
vancomycin as the single available and effective cell wall-inhibiting agent 
(Forbes et al., 1998). From an epidemiological point of view, plasmid 
resistance was most important, since resistance in this form was 
transmissible and may be associated with other properties that enable a 
microorganism to colonize and invade a susceptible host (Brody, 1994). 
The wide spread use of antibiotic therapy, especially in hospitals, has led to 
 the spread of R-plasmids among pathogenic bacteria. These might explain 
the high multi-resistance observed in this study. 
Antibiotic multi-resistance of some bacteria may be due to the 
resistance plasmids (R-plasmids), which contain genes that render the host 
bacterium resistant to sulphonamides, streptomycin, chloramphenicol, 
kanamycin and tetracycline. Some R-plasmids confer resistance to up to 
eight different antibiotics (Carter, 1985; Schlegel, 1995). This property of 
several antibiotics resistance could be transferred from one bacterium to 
another by simple cell-to-cell contact during conjugation (Carter, 1985; 
Schlegel, 1995). Some R-plasmids have an extensive host range and can 
transfer between several genera (Carter, 1985; Schlegel, 1995). This could 
explain the wide distribution of multi-antibiotic resistance observed in this 
study.  
Also transposon (Tn element) which sometimes code for resistance to 
antibiotics such as penicillin, tetracycline and kanamycin etc, able to move 
between bacterial chromosomes and plasmids (Schlegel, 1995) and might 
attributed to high multi-antibiotic resistance observed in this investigation. 
Through the process of spontaneous mutation and selection by misuse and 
overuse of antibiotics, some bacteria develop inheritable multi-drug 
 resistance. This may be one of the factors contributed in multi-resistance 
observed in bacterial isolate of this study.  
Drug resistance has increased substantially in recent years and has 
reduced the value of formerly widely prescribed agents such as the 
sulphonamides and ampicillin (Hugo and Russell, 1989).             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
From this study it can be concluded that: -  
1-  The most common bacterium isolated was Staphylococcus spp., 
which accounted for 72.2% of the total isolation.  
 2-  The result of antibiotics sensitivity testing showed response and 
resistance of the different isolation to different antibiotics were 
varied.  
3-  Staphylococci isolates collected from infected human wound were 
found completely sensitive to vancomycin (100%) and those 
collected from human abscesses showed high sensitivity to 
vancomycin (87.5%).  
4-  Corynebacteria, E.coli, klebsiella and pseudomonas isolate showed 
complete resistance to penicillin (100%). E.coli and klebsiella 
isolated from mastitic cows and goat's milk showed complete 
resistance to clindamycin (100%). All pseudomonas strains isolated 
from human and animal sources showed high resistance to 
erythromycin and clindamycin (100%).  
5-  E.coli isolated from human abscesses and infected equine uterus, 
klebsiella strains isolated from infected human wound, infected 
human ear and mastitic cows and goat’s milk and all pseudomonas 
isolated from human and animal sources showed completely 
resistance to vancomycin (100%).  
 6-  Many organisms isolated showed resistance to more than one 
antimicrobial agent.  
7-  E.coli strains isolated from human abscesses showed the highest 
multi-drug resistance, up to 11 antimicrobial drugs.  
8-  The highest multi-drug resistance Gram-positive and Gram-
negative bacteria were isolated from infected human wound.  
9- Drug-resistance is recorded for each species; each drug and each site 
of collection, this give useful information to choice the drug of 
choice sensitivity testing result is received.  
10- As high multi-resistant strains of klebsiella were isolated from 
mastitic milk, thus milk might play a role in dissemination of high 
multi-resistant strains among human population.  
 
 RECOMMENDATION 
The findings of this study indicated that to compact infectious 
bacterial diseases, the followings are recommended: -  
1- When clinical diagnosis is established, bacteriological laboratory 
should be consulted to determine the most effective antibiotic. 
However, when treatment has to be started before the laboratory 
report is received; it should be modified if report indicated.  
2- When antimicrobial drugs are administered they should be given in 
full therapeutic doses for adequate period.  
3- Where laboratory facilities are not available combination of two or 
more antibiotics therapy is advisable to lessen the frequency of 
emergency of antibiotics resistance by mutation and others genetic 
variation mechanisms.  
4- Antibiotic which became less effective or not effective should be 
withdraw from medical and veterinary uses for sometimes.  
5- Purchase of antibiotics from pharmacy without prescription should 
prohibited by law.  
6- Further extensive work should be carried out in Khartoum states and 
in other States of the Sudan, to survey the prevalence of 
antibacterial drug resistance.      
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